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Abbreviations 
CARD   Aminoterminal caspase recruitment domain 
CD   Cluster of differentiation 
CFU   Colony forming unit 
DAMPs  Damage-associated molecular patterns 
DC   Dendritic cell 
E. coli   Escherichia coli 
ELISA   Enzyme-linked immunosorbent assay 
Erm   Erythromycin 
FITC   Fluorescein isothiocyanate 
GFP   Green fluorescent protein 
H   Hours 
IL   Interleukin 
IFN   Interferon 
IKK   Inhibitor of NF-?B kinase  
IRF   IFN regulatory factor 
JNK   c-Jun N-terminal kinase 
LDH   Lactate dehydrogenase 
Lpp   Lipoprotein 
LPS   Lipopolysaccharide 
LTA   Lipoteichoic acid 
lgt   Gene encoding preprolipoprotein diacylglyceryl transferase 
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lnt   Gene encoding N-acyltransferase 
lsp   Gene encoding lipoprotein signal peptidase II 
MAPK   Mitogen-activated protein kinase 
MDP   muramyl dipeptide 
MFI   Mean fluorescence intensity 
MHC   Major histocompatibility complex 
min   Minutes 
MOI   Multiplicity of infection 
MRSA   Methicillin-resistant Staphylococcus aureus 
MyD88  Myeloid differentiation factor 88 
NF-?B   Nuclear factor ?B 
NOD   Nucleotide oligomerization domain 
NLR   NOD-like receptor 
OD   Optical density 
ON   Overnight 
Pam2CSK4  Palmitoyl-2-cysteine-serine-lysine 
Pam3CSK4  Palmitoyl-3-cysteine-serine-lysine 
PAMPs  Pathogen-associated molecular patterns 
PE   Phycoerythrin 
RIP   Receptor-interacting serine-threonine kinase 
PMN   Polymorphonuclear leukocyte 
PRR   Pattern recognition receptor 
RT   Room temperature (about 23 °C) 
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S. aureus  Staphylococcus aureus 
SD   Standard deviation 
SEM   Standard error mean 
Tat   Twin arginine translocation pathway 
TCF   Tissue cage fluid 
TCR   T cell receptor 
TH cell   T helper cell 
TIR   Toll/IL-1-receptor  
TIRAP   TIR-domain-containing adaptor protein 
TRAM   TRIF-related adaptor molecule 
TRIF   TIR domain-containing adaptor protein 
TLR   Toll-like receptor 
TNF   Tumor necrosis factor 
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Summary 
Staphylococcus (S.) aureus is a very successful pathogen due to its immune evasion 
strategies. Besides toxins and adhesins, it expresses membrane lipoproteins (Lpp), which 
are bound by the pattern recognition receptor Toll-like receptor (TLR) 2 in the host. 
Recognition of Lpp activates the MyD88-signaling pathway, which allows mounting a 
strong inflammatory response. Interestingly, evolution did not select for S. aureus 
mutants deficient in lipid modification of proteins suggesting that Lpp, besides their 
signaling potential to the host, offer an advantage for S. aureus. The aim of this thesis 
was to identify the benefit of Lpp maturation for S. aureus and the contribution of Lpp-
TLR2-signaling to the pathogenesis of staphylococcal disease in mouse infection models.  
 
In the first part, we demonstrate the strong cytokine-activating potential of Lpp in murine 
macrophages, which was associated with the presence of TLR2 in the host. In a systemic 
infection model, Lpp-TLR2 activation was less contributing to inflammation and S. 
aureus killing than MyD88-signaling. This indicates that other receptors signaling to 
MyD88 participate in the antimicrobial response. We further showed in systemic 
infection that maturation of Lpp facilitates survival of S. aureus in organs due to 
improved iron acquisition. Studies on growth, uptake, and intracellular storage of iron in 
vitro confirmed the iron dependence of S. aureus. It is long known, that the 
immunocompetent host restricts iron in an infection. We show that Lpp enhanced S. 
aureus growth in the iron-overloaded immunocompetent host, while they were not 
required in the iron rich environment in the MyD88-deficient host. Interestingly, iron-
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restricted S. aureus could not profit from Lpp for growth as long as the infected mice 
were fully immunocompetent. Only in mice deficient in MyD88-dependent inflammation 
iron-restricted S. aureus used Lpp for growth. In summary, the results in part 1 strongly 
suggest that Lpp confer a growth and survival advantage although allowing innate 
immune responses mediated through TLR2-MyD88-signaling.  
 
In the second part, data are presented showing that Lpp released during growth activate 
TLR2-signaling but engulfment of S. aureus enhances cytokine production. Lpp 
enhanced phagocytosis by macrophages and intracellular survival of S. aureus. 
Moreover, Lpp-TLR2-signaling induced cathepsin B-mediated cytotoxicity in 
macrophages. An effect of Lpp on various interactions of S. aureus with PMN was not 
found in vitro and in vivo, whereas Lpp enhanced invasion of S. aureus in endothelial 
cells in vitro. These results point to an additional survival advantage by maturation of 
Lpp in S. aureus due to improved evasion from extracellular killing, better intracellular 
survival, and escape from the phagosome. 
 
In the third part, we demonstrate that Lpp-TLR2-MyD88-signaling is important for 
activation of DCs to induce differentiation of naïve CD4
+
 into IFN-?- and IL-17-
producing T cells in vitro. Induction of Lpp-TLR2-signaling was also required to 
promote IFN-? release by naïve CD8+ T cells. In systemic infection, restimulated spleen 
T cells produced MyD88-dependent IFN-? and TLR2-MyD88-dependent IL-17. 
Surprisingly, the presence of B and T cells diminished eradication of S. aureus from 
organs during early sepsis. These data show that detection of invading S. aureus by DCs 
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leads to the development of adaptive immune responses, which are not always beneficial 
for eradication of S. aureus.  
 
In the fourth part, the role of other pattern recognition receptors (PRRs) in staphylococcal 
infection was examined. TLR9 and NOD2, in contrast to IL-1R, had a positive effect on 
cytokine induction in macrophages and in systemic infection, whereas killing was not 
affected. In inflammation and bacterial killing during S. aureus infection, TLR2 and 
TLR9, which both require the MyD88-adaptor, were found to cooperate. These data 
suggest that concurrent activation of different PRRs elicit a strong antimicrobial defense 
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1 General Introduction 
1.1 Staphylococcus aureus  
1.1.1 Pathogenesis and epidemiology 
Staphylococcus (S.) aureus is an extracellular Gram-positive pathogen colonizing the 
skin and mucosa of humans. About 20% of the population is persistently colonized in the 
nose, while another 50% are intermittent carriers. The comparison of disease-causing 
isolates with carriage isolates revealed that these isolates had a similar population 
structure (1). Therefore, carriage of S. aureus is an important risk factor for invasive 
diseases (2) and about 80% of blood infections originate from colonies in the nasal 
mucosa (3).  
S. aureus can cause toxin-mediated diseases such as toxic shock syndrome. In addition, S. 
aureus can cause benign local infections such as furunculosis. If the local innate immune 
defense with polymorphonuclear lymphocytes (PMN) is insufficient, S. aureus can 
disseminate and finally cause severe organ diseases like osteomyelitis and lead to life-
threatening infections like endocarditis and sepsis.  
In the last decades, the incidence of staphylococcal infections has increased due to 
increased numbers of patients with risk factors such as implants and immunodeficiencies. 
Infections with resistant strains impose a threat to the society, which makes the 
development of novel therapies against S. aureus essential. However, identification of 
virulence factors is difficult due to horizontal gene transfer of mobile genetic elements 
(4) and further a lineage specific virulence in strains with close genetic relationship could 
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not be linked to the expression of specific virulence factors (5, 6). For S. aureus-host 
interactions, host factors such as polymorphisms in genes influence the pathogenesis of S. 
aureus. Therefore, identifying exactly which genes or gene combinations are necessary 
for infections or which ones could be targeted by new therapies remains difficult.  
 
1.1.2 The staphylococcal cell envelope 
The structural integrity and shape of S. aureus is maintained by the cell wall, a large 
mesh-like polymer, which surrounds the cell and is essential for viability (7, 8). The main 
constituent of the cell wall is peptidoglycan, a polymer made of muropeptides 
synthesized as pentapeptide chains linked to disaccharides composed of N-acetylmuramic 
acid and N-acetylglucosamine. This peptidoglycan layer contains different molecules 
including (lipo-) teichoic acids (LTA), and covalently and non-covalently associated 
proteins. Wall teichoic acids and lipoteichoic acids are composed of a polymer of 
glycerolphosphate. The wall teichoic acids are covalently linked to the peptidoglycan, 
whereas lipoteichoic acids are anchored in the outer leaflet of the cytoplasmic membrane 
by a glycolipid. Surface-associated proteins are transported through the bacterial 
membrane and further modified for attachment to the cell wall or anchoring in the 
bacterial membrane known as lipoproteins (Lpp).  
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1.1.3 Staphylococcal Lipoproteins 
Lipopro tein biogenesis 
The pathway for Lpp biogenesis is unique to bacteria and was first established in 
Escherichia (E.) coli (9). S. aureus Lpp are secreted by the general secretory (Sec) or 
twin arginine protein transport (Tat) pathway (Figure 1). The Lpp precursor is exported 
with a conserved motif L-3-[A/S/T]-2-[G/A]-1-C+1 (lipobox) in which the conserved 
cysteine residue is required for lipidation (10). The phosphatidyl glycerol diacylglyceryl 
transferase (Lgt) adds a diacylglyceryl moiety to the cysteine via a thioether linkage (11) 
and the Lpp-specific type II signal peptidase (Lsp) cleaves the signal peptide form the 
pre-Lpp. In the final maturation step in Gram-negative bacteria, the N-acyltransferase 
(Lnt) attaches a third fatty acid to the lipid-modified cysteine yielding mature triacylated 
Lpp. While one group identified diacylated Lpp in S. aureus (12), which is in agreement 
with the lack of a lnt-gene homolog in S. aureus (11), Kurokawa et al. found a triacylated 
Lpp (13). They assumed that another acyltransferase further modifies diacylated Lpp in S. 
aureus. For that reason the lipid-linkage of staphylococcal Lpp remains unclear. 
 
 




Figure 1. The lipoprotein biogenesis pathway in S. aureus. Lpp are translated with a conserved 
motif (the lipobox) and a N-terminal signal peptide (green). Precursor-Lpp are translocated 
through the membrane by the Sec or Tat system (yellow). The phosphatidyl glycerol 
diacylglyceryl transferase (Lgt, red) covalently binds a diacylglycerol group to the conserved 
cysteine in the lipobox, and the lipoprotein-specific type II signal peptidase (Lsp, blue) cleaves 
off the signal peptide. An acyltransferase (?, gray) might attach an additional lipid to the cysteine 
in S. aureus.  
 
Functions of staphylococcal Lpp 
Using bioinformatic approaches, about 50 genes encoding lipoproteins were predicted out 
of ~2500 open reading frames in the genome of S. aureus (14). Mature Lpp function 
within the subcellular region between the plasma membrane and the cell wall. About 40% 
of the Lpp genes encode for substrate binding proteins of ATP-binding cassette (ABC) 
transporter to import nutrients in Gram-positive bacteria (10). High substrate affinities of 
Lpp maintain the continuous import of molecules from the environment including sugars, 
siderophores, divalent metal ion, anions (such as phosphate and sulfate), amino acids, 
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oligopeptides, and nucleotides (10). In S. aureus, some Lpp are well characterized while 
other Lpp are only predicted to function in binding of oligopeptides (OppA), glycyl 
methionine (GmpC), glycine betaine/carnitine/choline (OpuCC), manganese (MntA), 
molybdate (ModA), and a beta-lactamase precursor (BlaZ) (11, 15, 16). A number of 
identified Lpp are required for siderophore or heme acquisition in S. aureus including 
FhuD1/FhuD2, SirA, SstD, SitC, HtsA, and IsdE (17-21). Other staphylococcal Lpp like 
the peptidyl-prolyl cis/trans isomerase (PrsA) and the thiol-disulfide oxidoreductase 
(DsbA) are involved in folding and formation of disulphide bonds of exported proteins, 
respectively (11, 15, 22). Nevertheless, most of the proteins containing the lipobox are 
hypothetical without known function (15). 
 
1.2 Pattern recognition receptors 
The immune system protects the organism against pathogens like bacteria, fungi, viruses, 
and parasites. The mammalian immune system consists of innate and adaptive immunity 
(23). Innate immunity is referred as first line defense mechanism to recognize the 
pathogen, induce antimicrobial defense and is crucial for establishing and modulating 
adaptive immune responses (23-25). Pattern recognition receptors (PRRs) are germ-line 
encoded and recognize conserved molecules on the bacterial surface, also called 
pathogen-associated molecular patterns (PAMPs). Among the PRRs, the signaling 
receptors including the Toll-like receptor (TLR) family and the nucleotide 
oligomerization domain (NOD) receptor family activate signal transduction (26). PRRs 
are expressed on various immune cells including macrophages, dendritic cells, B cells, 
specific types of T cells, as well as non-immune cells such as fibroblasts and epithelial 
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cells. PRRs basically serve three distinct functions: (i) sensing the presence of bacteria, 
(ii) inducing an immediate antimicrobial response, and (iii) promoting the development 
of a long-lasting adaptive response (27). 
 
1.2.1 Signaling of Toll-like receptors in innate immunity against bacteria 
The TLR family comprises 10 and 12 receptors in humans and mice, respectively (28, 
29). While certain TLRs (TLR1, 2, 4, 5, and 6) are expressed on the cell surface and 
migrate to phagosomes after activation, others (TLR3, 7, 8, and 9) are found in 
intracellular compartments. Recognition of specific ligands induces the formation of 
heterodimers as reported for TLR2 together with TLR1 or TLR6, or homodimers as 
reported for other TLRs (30). The most extensively studied TLRs, TLR2 and TLR4 were 
found to recognize lipid structures of microbes. TLR2 together with TLR1 or TLR6 binds 
Lpp and LTA from bacteria as proposed by crystal structure analysis (30, 31). TLR4 is 
primarily responsible for inflammatory responses to bacterial lipopolysaccharide (LPS) 
from Gram-negative bacteria (32). Other TLRs sense proteins and nucleic acids. TLR5 
detects flagellin that is required for bacterial motility (33). TLR9 recognizes CpG motifs 
in bacterial DNA (34, 35), whereas TLR7 seems to be responsible for RNA sensing (36). 
However, a single microbe is recognized by different TLRs simultaneously, which share 
and also differ in signaling pathways. 
TLRs initiate signaling through a cytoplasmic domain called Toll/IL-1 receptor 
homology (TIR) domain. As extensively reviewed, signaling adaptor molecules also 
contain a TIR domain to bind to the receptor, including myeloid differentiation factor 88 
(MyD88), TIR domain-containing adapter protein (TIRAP), TIR domain-containing 
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adapter-inducing interferon-? (TRIF), and TRIF-related adapter molecule (TRAM). The 
usage of these adapter molecules varies between TLRs and depending of the activated 




Figure 2. Model for Toll-like receptor signaling. Toll-like receptors (TLRs) involved in 
bacterial recognition and some of their representative bacterial ligands are shown. Bacterial Lpp, 
for example, can be recognized at the cell surface by TLR2 dimerized with either TLR1 or TLR6 
through the TIR-containing adaptor MyD88 and TIRAP to activate cells through NF-?B and 
MAPKs (not shown). TLR4 homodimers recognize LPS and activate cells through MyD88 and 
TIRAP via the cell surface or TRAM and TRIF via the endosomal pathway. Recruiting of TRIF 
is required for the activation of IRF-3 resulting in the production of type I IFNs and late 
activation of NF-?B. TLR7 and 9 recognize nucleic acids in the endosome. TLR7/9-mediated 
signaling pathways are through TRIF and MyD88, respectively, resulting in the induction of 
proinflammatory cytokines and type I IFNs. 
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For example, bacterial Lpp activate TLR2 and signal by the MyD88-dependent pathway 
with MyD88 and TIRAP (also known as Mal) to activate the transcription factor NF-?B 
and mitogen-activated protein kinases (MAPKs) resulting in the production of 
proinflammatory cytokines, including tumor necrosis factor (TNF). LPS stimulation of 
TLR4 activates signaling pathways through TIRAP-MyD88 and TRAM-TRIF, which 
induce the production of proinflammatory cytokines and type I interferons (IFNs), 
respectively (37). TRIF and TRAM induce the phosphorylation and dimerization of the 
transcription factor IFN regulatory factor-3 (IRF3), leading to the production of type I 
IFNs and can later also activate NF-?B signaling (38-43).  
 
1.2.2 Signaling of NOD receptors in innate immunity against bacteria 
The NOD-like receptors (NLRs) fill a different niche than TLRs by sensing in the 
cytoplasm. NOD receptors, including NOD1 and NOD2 are signaling receptors involved 
in recognition of microorganisms (44-46). NOD1 recognizes the intracellular 
peptidoglycan fragment M-TriDAP (L-Ala-D-Glu-meso-diaminopimelic acid) from 
Gram-negative bacteria (47, 48). NOD2 detects the conserved structure within 
peptidoglycan from Gram-negative and Gram-positive bacterial cell walls called 
muramyl dipeptide (MDP) (Figure 3) (49, 50). Ligand binding by NOD1 or NOD2 leads 
to homo-oligomerization of the proteins, leading to the recruitment of caspase activation 
and recruitment domain (CARD)-containing adaptor molecules that are responsible for 
signaling. NOD1 and NOD2 interact with receptor-interacting protein 2 (RIP-2), which 
binds the inhibitor of NF-?B kinase ? (IKK?) leading to the activation of 
proinflammatory responses mediated by NF-?B (51, 52). In addition to activation of NF-
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?B, NOD2 activates the MAPK-signaling pathways via p38 and c-Jun N-terminal kinase 
(JNK). 
 
Figure 3. Pathway of NOD2 activation. NOD2 activates the canonical MDP activation pathway 
involving the kinase RIP2. RIP2 becomes ubiquitinated (Ub) and subsequently activates NF-?B 
and MAPK leading to inflammatory gene expression. (Adapted from (53)). 
 
1.2.3 PRRs and adaptive immune responses against bacteria 
Detection of infections by PRRs initiates the innate and the adaptive immune response. 
While innate immunity is rapid and not antigen-specific, adaptive immunity confers a 
highly specific and long-lasting immune response against invading pathogens. To 
efficiently eradicate pathogens both immune systems have to act together. Professional 
antigen-presenting cells, such as macrophages, dendritic cells (DCs), and B cells engulf 
bacteria and present bacterial antigens on Major Histocompatibility Complex (MHC) 
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class II molecules to CD4
+
 T cells (signal 1). DCs are activated by PRRs and induce the 
upregulation of MHC molecules, costimulatory molecules (signal 2), and cytokines 
(signal 3) (54). CD4
+
 T cells activate and regulate B cells, CD8
+
 T cells, and other 
inflammatory cells. CD4
+
 T cells differentiate into cells that produce a special set of 
cytokines, which specify them as T helper 1 (TH1) cells, TH2 cells, TH17 cells, or 
regulatory T (Treg) cells (Figure 4).  
 
 
Figure 4. Subsets of T helper cells. Depending on the cytokine milieu present at the time of the 
initial engagement of the TCR and costimulatory receptors in the peripheral immune 
compartment, naïve CD4
+
 T cells can differentiate into various subsets of T helper cells (TH1, 
TH2, and TH17). However, in the presence of TGF-?, naïve T cells convert into FOXP3-
expressing induced Treg (iTreg) cells. For each T helper cell differentiation program, specific 
transcription factors have been identified as master regulators (T-bet, GATA3, and ROR-?t). 
Terminally differentiated T helper cells are characterized by a specific combination of effector 
cytokines that orchestrate specific and distinct effector functions of the adaptive immune system. 
(adapted from (55)). 
 
TH1 cells are effective inducers of cellular immune responses, involving enhancement of 
antimicrobial activity of macrophages and consequently increased efficiency in lysing 
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microorganisms in intracellular compartments, whereas TH2 cells are very effective in 
helping B cells to develop into antibody-producing plasma cells. TH17 cells are required 
in defense against extracellular pathogens and Treg cells are a specialized CD4
+
 cell type 
that can suppress the responses of other T cells. T and B cells mount an adaptive, antigen-
specific immune response, which is critical to control the infection and to eradicate the 
invasive bacterium. 
 
1.2.4 Recognition of S. aureus by PRRs  
Surface structures of S. aureus bind complement and antibodies, which allow 
phagocytosis of opsonized bacteria by complement and Fc receptors, respectively.  
It has been shown in different infection models that several PRRs are involved in the host 
response against S. aureus. Scavenger receptors are required for recognition since CD36
-/-
 
mice are highly susceptible to S. aureus (56), whereas CD14 is not contributing in a 
murine brain abscess model (57). The lack of TLR2 increases the susceptibility of mice 
in systemic and subcutaneous infections and leads to increased numbers of S. aureus in a 
nasal carriage model (56, 58-60). TLR7 and TLR9 are involved in recognition of RNA 
and DNA from S. aureus (61). However, TLR9
-/-
 mice did not display any difference 
compared to C57BL/6 mice in a corneal infection model (62). The role of TLR7 in 
S. aureus infection remains to be elucidated.  
Like TLRs, IL-1R uses the common adaptor MyD88. IL-1R-deficiency leads to increased 
bacterial burden in systemic and subcutaneous infection (63, 64). In line with the results 
found for single receptor knock-outs, MyD88
-/-
 mice are highly susceptible in murine 
infection models (58, 59, 62, 64, 65). Mice deficient in NOD2 are impaired in bacterial 
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killing, but not in cell recruitment (66, 67). In addition to these receptors, other known 
and yet unknown PRRs may be involved in recognition of S. aureus.  
 
1.3 Competition for iron by S. aureus and the host 
Iron availability is efficiently regulated in the host, which sequesters iron within cells or 
by proteins to avoid damage due to the high oxidative potential of iron. Most iron in the 
human body is bound as hemoglobin in erythrocytes. Iron for hemoglobin synthesis is 
recycled by phagocytosis of erythrocytes by macrophages in the spleen and the liver. 
Recycled iron is exported through ferroportin, binds to transferrin in blood circulation, 
and is delivered into bone marrow for hematopoiesis. Therefore, the amount of free iron 
is extremely low in serum (10
-24
 M). The challenge for S. aureus is to obtain sufficient 
quantities of iron (10
-6
 M) to maintain essential catalytic functions of enzymes mainly 
involved in the respiratory chain.  
S. aureus circumvents iron limitation in the host by the release of iron-binding 
siderophores and uptake of those as well as direct uptake of heme by iron uptake ABC 
transporters (68). All uptake systems have common characteristics of ABC-transporters; 
a substrate binding protein anchored as Lpp in the membrane, a permease for 
translocation through the membrane, and an energy providing ATPase in the cytoplasm. 
These transporters are controlled by the ferric uptake regulator (fur) (69, 70), which 
represses transcription of genes in the presence of iron. Another sensor of intracellular 
iron is the aconitase, which can modulate the translation of mRNA under iron-limiting 
conditions (71).  
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Invading S. aureus are believed to gain access to iron by lysis of erythrocytes, which 
were recently also found in abscesses (72). The low iron availability in the host is known 
to upregulate iron uptake systems and cytotoxins such as hemolysins in S. aureus 
(Gordon Conference 2009). The host immediately responds with antimicrobial defense 
mechanisms including enhanced expression of transferrin receptor in liver and spleen 
cells to sequester iron (73) and release of lipocalin to bind siderophores (74). 
Inflammatory cytokines (e.g. IL-6) induce the release of hepcidin (75), which down-
regulates ferroportin, the exporter of iron from cells into serum (76, 77). This leads to the 
reduction of free iron and together with erythropoesis results in iron-limiting conditions 
in the host. Thus, the host sustains iron levels at growth limiting concentrations for 
S. aureus. Therefore, the recognition by PRRs e.g. Lpp by TLR2 may be a handicap for 
S. aureus considering that host cells and other antimicrobial defense mechanisms are 
activated and iron is sequestered within host cells. On the other hand, S. aureus requires 
Lpp for the import of iron from heme, siderophores, and other iron-containing molecules 
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2 Aim of the thesis 
Maturation of Lpp allows the host to mount a strong immune response by TLR2-
signaling, which is generally viewed to be a drawback for S. aureus. However, no 
mutants deficient in Lpp maturation are found among staphylococci suggesting a benefit 
for S. aureus in keeping Lpp maturation. This might be due to the fact that most S. aureus 
Lpp are components of nutrient- and metal-uptake systems important for maintaining 
metabolism and growth. Therefore, the question arose how S. aureus profits from Lpp 
maturation in systemic infection.  
 
The first aim was to understand the role of Lpp maturation in viable S. aureus for the 
activation of TLR2- and MyD88-signaling in macrophages. A special interest was to 
identify the contribution of Lpp and TLR2-MyD88-signaling in the pathogenesis of 
systemic staphylococcal disease in mice. In addition, the contribution of Lpp maturation 
in iron acquisition by S. aureus was investigated in the context of iron sequestration in 
inflammation.  
Although regarded to be an extracellular pathogen, S. aureus is able to invade a variety of 
non-professional phagocytes and can also survive engulfment by professional 
phagocytes. In part 2, we therefore intended to investigate the role of Lpp maturation and 
TLR2-MyD88-signaling on phagocytosis, intracellular survival, and escape from 
phagosomes through induction of cell death. Further, the necessity of bacterial 
engulfment for triggering cytokines was examined. 
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The innate immunity “instructs” adaptive immune cells by providing signals for 
activation and proliferation. In part 3, we aimed to evaluate the requirements of Lpp-
TLR2-signaling in DCs to promote the activation of T cells and more importantly, the 
differentiation of T cells into TH1, TH2, or TH17 lineages. Finally, we ask for the effects 
of adaptive immune cells in S. aureus disease.  
 
The aim in part 4 was to investigate which intracellular and extracellular PRRs – besides 
TLR2 – are involved in sensing of S. aureus or S. aureus-induced cytokines. Therefore, 
the function of TLR9, IL-1R, and NOD2 was studied in relation of cytokine induction 
and systemic infection. Moreover, the contribution of other MyD88-dependent receptors 
to cytokine responses and additive effects of TLR2 with TLR9 were investigated. 
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3.1 Part 1 – Lipoproteins in Staphylococcus aureus mediate 
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Supplemental Fig. 1. Lpp enhance virulence of S. aureus Newman in sepsis. 
(A) Survival of C57BL/6 mice infected with 1 x 10
8
 CFU of Newman wt (filled, n = 5) and ?lgt 
(open, n = 5). (B-G) Mice were infected with 1 x 10
6
 CFU of Newman wt and ?lgt. (B) Weight 
loss of C57BL/6 mice during infection, (C) bacterial load in spleen, liver, both kidneys, and both 
knees on day 7 and (D) plasma IL-6 level on day 7. Data are represented as mean ± SD for weight 
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loss and cytokines and median for CFU/mg of at least 9 mice per group. (E) One day after 
infection (n = 5 per group), isolated splenocytes were restimulated with the corresponding strain 
for 24 h in vitro. TNF, IL-6, IL-10, IL-1?, and MIP-2 in supernatants were analyzed by ELISA. 
(F) Survival and (G) weight loss of MyD88
-/-
 mice infected with 1 x 10
6
 CFU of Newman wt 
(filled, n = 5) and ?lgt (open, n = 5). (H) Streptonigrin sensitivity for 30 min of Newman wt and 
?lgt grown overnight in RPMI with 250 ?M Dipyridyl. Data show one representative out of three 
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3.2 Part 2 – Staphylococcal lipoproteins and their role in bacterial 




  Results – Part 2 
 49
 
  Results – Part 2 
 50 
 
  Results – Part 2 
 51
 
  Results – Part 2 
 52 
 
  Results – Part 2 
 53
 
  Results – Part 2 
 54 
  Results – Part 2 
 55
3.2.1 Summary of additionally published results 
In this review, additional results concerning the function of Lpp in S. aureus are 
published. Firstly, maturation of Lpp increases phagocytosis of S. aureus by macrophages 
depending on the presence of MyD88 but not TLR2. Furthermore, Lpp confer an 
advantage for survival and escape of S. aureus after engulfment by macrophages and 
Lpp-TLR2-mediated cell death by activation of cathepsin B, respectively. Both 
mechanisms might improve the escape from intracellular organelles into the cytoplasm. 
Secondly, we demonstrate that released Lpp induce TLR2-signaling and production of 
cytokines. Internalization of S. aureus enhances the total amount of cytokines suggesting 
that Lpp are mainly detected by TLR2 in the phagosome. Thirdly, in contrast to 
macrophages, Lpp have no effect on phagocytosis or survival of S. aureus in PMN in 
vitro or in a tissue cage model, but augment the capacity of S. aureus to invade 
endothelial cells. In summary, we extend the knowledge about maturation of 
staphylococcal Lpp in infection by elucidating its function in engulfment, intracellular 
survival, and cell death in macrophages. 
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3.2.2 Material and Methods 
Stimulation of macrophages with bacterial supernatants 








 mice were prepared 
as described in Part 1 Material and Methods.  
Adherent macrophages were stimulated with sterile-filtered (0.22 ?m) bacterial 
supernatants from S. aureus wt and ?lgt grown ON in RPMI 1640 complete. At indicated 
time points, NF-?B translocation and cytokines were analyzed as described in Part 1.  
 
Phagocytosis and killing assay 
Macrophages were infected with viable S. aureus strains and their isogenic mutants in 
RPMI 1640 complete (MOI 10). To test the contribution of complement and mannose 
receptors, phagocytosis was also performed in serum-free RPMI complete and in 
presence of 10 mg/ml mannan (Sigma). After 1h of phagocytosis, extracellular bacteria 
were degraded by 20 U lysostaphin. Intracellular bacteria were determined after lysis of 
macrophages with water (pH 11) by plating serial dilutions on MHA plates. For killing 
assays, supernatants were replaced by medium containing 100 ?g/ml gentamicin. After 
24 and 48h intracellular bacteria were determined as above. Additionally, lactate 
dehydrogenase (LDH) in the supernatants of infected macrophages with or without 50 
nM zVAD-fmk or zFA-fmk was determined after 18h of infection with Cytotox 96
®
 
(Promega) according to the manufacture’s instructions. 10 ?g/mL cycloheximide (CHX, 
Sigma) was used as positive control. 
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Adhesion and Invasion assay 
Human umbilical vein endothelial cells (HUVECs) were seeded at 3 x 10
4
 cells/well into 
24-well plates. HUVECs were infected with SA113 wt and ?lgt (MOI 10) at 37°C and 
5% CO2. After 1h, cells were washed with PBS and trypsinized to detach. To determine 
total bacteria, cells were lysed with water (pH 11) and serial dilutions were plated on 
MHA to assess CFU. For invasion, remaining extracellular bacteria were killed by 50 U 
lysostaphin for 10 min before lysis and CFU plating. The number of adherent bacteria 
was calculated as the difference of total minus intracellular bacteria. 
 
Mice and tissue cage model 
C57BL/6 and TLR2
-/-
 female mice (12–14 weeks old) were anesthetized via i.p. injection 
of 100 mg/kg ketamine (Ketalar) and 20 mg/kg xylazinium and sterile Teflon tissue cages 
were implanted s.c. in the back, as described previously (1). Mice were treated with 
buprenophinum (2 mg/kg s.c.) after implantation. Two weeks after surgery, the sterility 
of tissue cages was verified. Mice were infected with indicated CFU of SA113 wt and 
?lgt in 200 ?l 0.9% NaCl. Mice were anesthetized by isofluorane (Minrad Inc., 
Bethlehem, PA, USA), and 100 ?l tissue cage fluid was percutaneously collected with 
EDTA at day 2, 5, and 8. Number of infiltrating cells was determined (Coulter counter) 
and growth of bacteria was assessed by plating serial dilutions on MHA plates. 
 
Preparation of peripheral blood-derived PMN 
Murine and human blood PMN were isolated by density gradient centrifugation on a 
discontinuous Percoll (Pharmacia Biotech AB, Uppsala, Schweden) gradient with 59% 
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(murine) or 53% (human) and 67% Percoll in PBS as described previously (2). The 
interface, which contains the PMN, was collected and contaminating erythrocytes were 
removed by hypotonic lysis in water. By morphologic criteria, the final cell preparation 
contained >95% PMN and was used for chemotaxis assays, phagocytosis, and killing 
assays. The viability of the cells was >95% as assessed by trypan blue exclusion.  
 
PMN phagocytosis and killing assay 
Murine and human blood PMN were resuspended in Dulbecco’s PBS (10% pooled 
mouse plasma and 10% pooled human serum, respectively) and infected with SA113 wt 
or ?lgt at MOI 10 for phagocytosis and MOI 1 for killing (GFP-expressing strains were 
used for phagocytosis) at 37°C, 200 rpm. Phagocytosis was determined as the percentage 
of GFP-positive cells by flow cytometry. For killing assay, PMN were lysed in water 
(pH 11) and serial dilutions were plated on MHA to enumerate surviving bacteria. 
 
Chemotaxis assay 
Chemotaxis of 1 x 10
5
 murine blood PMN attracted by staphylococcal supernatants or 
10
–7
 M synthetic formylated peptide (fMLP) was determined by using a 48 well camber 
as described recently (3, 4). Supernatants from ON  cultures of SA113 wt and ?lgt were 
sterile-filtered (0.22 ?m) and either directly used for stimulation, or washed twice with 
PBS in a 10 kDa concentrator (Amicon) and resuspended in equal volume TSB. PMNs 
migrated through a 3 ?m polycarbonate filter membrane (Costar) for 30 min at 37°C in 
5% CO2, in humidified air. After incubation, filters were removed, fixed, and stained with 
  Results – Part 2 
 59
Wright-Giemsa. Cells that migrated through the pores of the filter were counted by light 
microscopy (63x).  
 
Chemotaxis in peritonitis model 
Bacterial supernatants from ON cultures of SA113 wt and ?lgt grown in IMDM 
(Invitrogen) were sterile-filtered (0.22 ?m) and 2 ml were injected i.p. After 6 h, 
infiltrating cells were collected by peritoneal lavage with 6 ml RPMI-1640 complete 
medium, counted (Coulter counter) and spun on glass slides to differentiate recruited 
cells. 
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Abstract 
S. aureus infection activates through its lipoproteins (Lpp) toll-like receptor 2 (TLR2) 
signaling to MyD88; the subsequent innate immune response improves bacterial clearing 
and outcome. The impact of this activation upon dendritic cell (DC) and T cell function is 
unclear. Here, we used S. aureus Newman wild type and an isogenic mutant deficient in 
mature lipoproteins (?lgt) for DC infection in vitro. We show that Lpp contribute to DC 
activation by modest upregulation of surface CD40, CD80, and CD86 and by a strong 
secretion of inflammatory cytokines, including TNF, IL-6, IL-10, IL-1?, and IL-12p70. 
The enhancing effect of Lpp in DCs was dependent on sensing of S. aureus by TLR2 and 
on signaling via myeloid differentiation factor 88 (MyD88). Interleukin-1 receptor- (IL-
1R) or TLR9-signaling did not mediate the remarkable reduction of cytokine levels found 
in the absence of MyD88. Lpp and TLR2 also markedly contributed to IFN-? and IL-17 
production in CD4
+
 T cells and to IFN-? production in CD8+ T cells. In systemic 
infection with S. aureus, spleen cells from TLR2
-/-
 mice produced similar amounts of 
IFN-? and IL-10, but reduced levels of IL-17 compared to C57BL/6 mice. MyD88-/- mice 
were highly impaired in the production of all cytokines. The importance of the adaptive 
immune response after 6 days of infection was found to be negligible in systemic S. 
aureus infection, since Rag2
-/-
 mice had less bacterial load in kidneys and knees and less 
plasma IL-6 than C57BL/6 mice. Our data indicate that S. aureus is able to activate 
innate and adaptive immunity in a TLR2-MyD88 modulated manner; the host however 
does not profit from early adaptive immunity. 
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Introduction 
 A successful immune defense against pathogens results from an immediate innate and a 
long-lasting specific response, both processes are tightly connected and controlled. 
Dendritic cells (DCs) are indispensable for initiation and orchestration of adaptive 
immunity (1, 2). In peripheral organs, residing immature DCs phagocytose invading 
pathogens and get concurrently activated through pattern recognition receptors (PRRs) 
that sense conserved patterns on the microorganism. These pathogens associated 
molecular patterns (PAMPs) induce maturation of DCs including upregulation of MHC 
class II and costimulatory surface molecules, switch of chemokine receptors as well as 
production of inflammatory and anti-inflammatory cytokines (3). DCs migrate to the 
lymphoid tissue for presentation of Ag to lymphocytes (4), which get activated by direct 
contact with the DC. This interaction promotes the differentiation of CD4
+
 T cells into 
TH1, TH2, and TH17 cells.  
Like many other cells, DCs express PRRs, including all Toll-like receptors (TLRs), to 
sense PAMPs (5). After recognition of PAMPs, TLRs elicit signaling pathways through 
the myeloid differentiation factor 88 (MyD88) or TIR-domain-containing adapter-
inducing interferon-? (TRIF) proteins, leading to activation of nuclear factor (NF)-?B 
and other transcription factors (6) with subsequent upregulation of surface molecule and 
production of mediators. 
 
Staphylococcus (S.) aureus is one of the most important pathogens causing severe 
systemic infections like endocarditis or sepsis. Several staphylococcal molecules are 
known to act as PAMPs for TLRs. Infections of mice and macrophages with S. aureus 
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revealed that lipoproteins (Lpp) activate TLR2, which is required for early activation of 
the innate immune system (7-11), whereas TLR9, which allows DNA-induced responses, 
has no effect on innate immune responses or bacterial killing (7, 8, 10). TLR2 and TLR9 
signal exclusively through MyD88 and macrophages lacking MyD88 produce no or low 
levels of cytokines after recognition of S. aureus (9, 11). The failure of inflammatory 
defense is responsible for the increased susceptibility of these mice to staphylococcal 
infections (9-12). The results further indicate that other receptors beyond TLR2 and 
TLR9, which also signal through MyD88, participate in an effective immune response 
against S. aureus. Indeed, IL-1 receptor (IL-1R) and IL-18R were found to have an 
important role (12, 13).  
There is increasing evidence that additional endosomal TLRs or cytosolic PRR play a 
role in the innate defense and mediate an interferon (IFN) response to RNA or DNA of 
Gram-positive bacteria (14). Indeed, it was shown that plasmacytoid DCs (pDCs) are 
rather stimulated by staphylococcal DNA or RNA and TLR9 or TLR7 respectively (16). 
It remains however to be explored whether – as shown for group B streptococci – (14), 
staphylococcal RNA interacts with TLR7 in phagosomes of myeloid cell-derived DCs. 
Additionally, it remains to be investigated, whether staphylococcal ligands – similar to 
those from Listeria – induce in the cytosol NOD2-dependent IFN-? (15). 
Besides the unknown spectrum of S. aureus-activated PRR in DC, data on the skewing of 
an S. aureus-induced TH cell response are controversial. While one group found a TH2 
response after stimulation with enterotoxin B through a TLR2-dependent recognition 
(17), other studies reported a beneficial effect of TH1 responses by using antibodies or 
several knock-out mice (18-20). Additionally, DCs activated by S. aureus PGN promote 
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IL-17 production in memory TH cells possibly by amplification of TLR2-induced IL-23 
and IL-1 by NOD2 (21). In the absence of IL-17, mice were more often colonized with S. 
aureus (22). Nevertheless, IL-17 might be not only beneficial for the host, since it is 
known to recruit neutrophils (22) and S. aureus is able to reside in infected organs by 
attraction of neutrophils (23). Under these conditions, S. aureus survives although the 
adaptive immune response with IFN-? production was elicited.  
In the current study, we examined the capacity of S. aureus to activate DCs and whether 
these are able to promote differentiation of naïve T cells into TH1, TH2, and TH17 cells. 
We used S. aureus strain Newman and an isogenic mutant deficient in mature Lpp in 
order to evaluate their contribution to TLR2 activation. Our results demonstrate that Lpp 
enhance cytokine production in S. aureus-infected DCs by TLR2 and MyD88. Lpp-
TLR2-MyD88-signaling was required to initiate the production of IFN-? and IL-17 in 
naïve T cells in vitro, while only MyD88 was required for cytokine production during 
systemic infection. We further demonstrate that T cells are the major producers of IFN-? 
and IL-17 in vivo. However, both T nor B cells positively affect early sepsis as in their 
absence disease course was less severe and bacterial killing was improved.  
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Material and Methods 
Mice  















 mice were bred in the Animal House of the Department of Biomedicine, 





 mice were a kind gift from W. D. Hardt (ETH Zürich, Switzerland) and 
TLR2
-/-





mice from Antonius Rolink (DBM, University Hospital Basel, Switzerland), all 
backcrossed on C57BL/6 background for 10 generations.  
 
Antibodies and reagents  
Monoclonal antibodies recognizing CD3 (145-2C11), CD4 (GK1.5), CD8 (53-6.7), 
CD11c (N418), CD40
 





MHCII (M5/114.15.2) were purchased from Biolegend, eBioscience or Pharmingen. 
Streptavidin-phycoerythrin and Streptavidin-FITC were purchased from CALTAG 
laboratories. Normal rabbit serum was provided by the Animal Care Unit at the 
University Hospital Basel. Specificity of staining was confirmed with isotype-matched 
control antibodies. 
Pam2CSK4 and Pam3CSK4 were purchased from EMC microcollections (Germany) and 
smooth LPS from Streptococcus equi abortus was kindly provided by Marina 
Freudenberg (Max-Plank Institute for Immunobiology, Freiburg, Germany). Sandwich 
ELISAs were purchased from BD Biosciences and R&D Systems.  
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Bacterial strains and growth conditions  
In this study, we used Newman wt (24) and SA113 wt strains and their isogenic lgt::ermB 
(?lgt) mutants (9, 25). Bacteria were grown in TSB for 7h and subcultured overnight 
under the same conditions. Overnight cultures were washed in 0.9% NaCl (Bichsel, 
Switzerland) and used for sepsis. Each inoculum was assessed by CFU/ml counting on 
Mueller-Hinton agar (MHA) plates. For infection of DC, bacteria were further 
subcultured in TSB to end-log phase. When appropriate, TSB was supplemented with 10 
?g/ml erythromycin. 
 
Generation of DC 
DCs were generated as described (26, 27). Briefly, Bone marrow cells from tibia and 
femur were flushed with RPMI medium. Red blood cells were lysed and CD11b
+
 
BMDCs (DCs) were generated by plating of bone marrow progenitors in RPMI 1640 
supplemented with gentamicin, 2-mercaptoethanol (all from Invitrogen), 10% (vol/vol) 
heat-inactivated FBS (Gibco) and 10% conditioned medium from GM-CSF transduced 
X63 (28). After 3 days, non-adherent cells were removed and attached cells were further 
cultured in supplemented RPMI medium. On day 7 and 8, cells were harvested and 
analyzed for CD11c
+
 expression which was routinely 80-90% positive. 
 
Stimulation of DC 
For analysis of cytokine production in supernatants and surface marker expression, 1 x 
10
6
 DCs per well were cultured in 24 well plates in 1 ml RPMI 1640 containing GM-
CSF. DCs were stimulated with smooth lipopolysaccharide (1 ?g/ml), Pam2CSK4 (10 
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?g/ml), or Pam3CSK4 (10?g/ml). When stimulated with S. aureus, DCs were infected 
with viable S. aureus strains at a multiplicity of infection (MOI) of 10 bacteria per DC for 
1h. After phagocytosis, supernatants were replaced with RPMI 1640 containing 100 
?g/ml gentamicin and cells were further incubated. Supernatants were collected at 2 and 
18h post-infection or incubation with various stimuli. Cytokines in the supernatants were 
analyzed by sandwich ELISA per manufacture’s instructions (BD Biosciences). 
 
Phagocytosis of S. aureus by DC 
DCs (1 x 10
6
 cells) were infected for 1h with S. aureus at a MOI of 10. For phagocytosis, 
extracellular bacteria were killed by 50 U lysostaphin and cells were lysed with water 
(pH 11) to assess intracellular bacteria by plating serial dilutions on MHA plates.  
 
Flow cytometry 
Cell suspensions were stained in ice-cold PBS supplemented with 0.04% (vol/vol) FCS 
and 25 mM sodium azide for surface staining. Data were acquired on a CyAN Flow 
cytometer (Dako) and were analyzed with FlowJo software (TreeStar). 
 





 T cells from spleen of C57BL/6 background were purified by negative 
selection by MACS beads (Miltenyi Biotec). DCs (1 x 10
4
) were infected with S. aureus 
at a MOI of 10, bacteria were killed by Pen/Strep and gentamicin after 1h of infection. 
DCs were further co-cultured with purified T cells (5 x 10
4
) for 72 h in RPMI 1640 
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without GM-CSF. Supernatants were analyzed by sandwich ELISA and T cells were 
analyzed by flow cytometry for expression of CD69.  
 
Systemic infection 
Mice were infected intravenously with 1 x 10
6
 CFU of S. aureus Newman and SA113. 
Weight loss was monitored over the time of infection. On days 6 or day 28 after 
infection, mice were killed, bacterial load determined in organs by CFU plating. 
Cytokines in plasma were analyzed by ELISA. 
 
In vitro stimulation of splenocytes  
Spleen cells from infected mice were isolated 6 days after injection, mechanically 
disrupted (70 ?m meshes) followed by lysis of erythrocytes and resuspension in RPMI 
1640. In 96-well plates, 2 x 10
5
 cells were infected for 1h with the same viable bacteria as 
used for infection at a MOI of 1. Bacteria were killed with Pen/Strep and gentamicin to 
prevent bacterial growth. Supernatants were collected after 48h and cytokines were 
analyzed by sandwich ELISA. 
 
Statistical analysis  
Statistical analyses of data with Mann-Whitney t tests and two-way Anova were 
performed using Prism (GraphPad Software, Inc.). Values of p<0.05 are shown when 
differences in the compared data sets are significant.  
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Results 
S. aureus enhances maturation of mDC 
We were interested to know whether S. aureus supports maturation of DCs in a Lpp-
TLR2-MyD88-dependent manner. GM-CSF stimulation of bone-marrow cells resulted in 
the generation of 80-90% of immature CD11c
+
 BMDCs (DCs, data not shown). Infection 
with S. aureus Newman wt led to similar upregulation of surface MHC class II, but to a 
slightly higher CD80, CD86, and CD40
 





 mice (Figure 1A). In addition, infection of C57BL/6 DCs with Newman ?lgt 
led to comparable induction of MHCII (data not shown), and a slightly but not 
significantly lower upregulation of CD80, CD86, and CD40 than observed with Newman 
wt (Figure 1A). The synthetic lipopeptides Pam2CSK4 and Pam3CSK4 induced DC 
maturation dependent on TLR2 and MyD88 (data not shown) confirming that 
lipopeptides act as agonists of TLR2. The TLR4 agonist LPS, elicited strong maturation 




 mice. These controls indicate that LPS 
uses the TRIF pathway for TLR4-modulated expression of comolecules in DCs (Figure 
1A). Taken together, Lpp-TLR2-signaling by MyD88 in DCs weakly enhances induction 
of maturation markers after infection with viable S. aureus. 
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Figure 1. Staphylococcal Lpp enhance upregulation of comolecules and cytokines by TLR2-




 mice (gray) were 
incubated with medium (nc), S. aureus wt and ?lgt (MOI 10) for 1h. Fresh medium with 
gentamicin was added and DCs were further incubated for 18h. As a positive control, DCs were 
stimulated with 1 ?g/ml of smooth LPS for 18h. (A) Expression of CD40, CD80, and CD86 on 
the surface of CD11c
+
 DCs was determined by flow cytometry. Data show mean ± SD of mean 
fluorescence intensity (MFI) of at least three independent experiments. (B) TNF, IL-6, IL-10, IL-
1?, and IL-12 levels in the supernatants of DCs were measured by ELISA. Data are represented 
as mean ± SEM of 3-5 independent experiments. C57BL/6-DC infected with wt vs. all other 
groups, *: p<0.05, **: p<0.01, ***: p<0.001 (Mann-Whitney test).  
 
Lpp-TLR2-MyD88-signaling is required for cytokine release in DCs 
DCs produce cytokines in response to synthetic or purified TLR agonists (29). The 
response to live bacteria may differ from that to individual TLR ligands as pathogens 
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express several PAMP and thus trigger combinations of TLRs, which may mitigate the 
individual pathways and lead to synergistic effects. Therefore, we investigated the 
production of cytokines in S. aureus-infected DCs to see results of a composite TLR 
activation by these bacteria. 
18h after infection, Newman wt induced higher levels of TNF, IL-6, IL-10, IL-1?, and 
IL-12p70 in C57BL/6 DCs than in TLR2
-/-
 DCs (Figure 1B). DCs from MyD88
-/-
 mice 
were highly impaired in the production all cytokines compared to C57BL/6 cells after 
infection (Figure 1B). The TLR2-dependent cytokine response with Newman was mainly 
mediated by Lpp since Newman ?lgt induced similar quantities as Newman wt in TLR2-/- 
DCs (Figure 1B and data not shown). Cytokine induction by LPS was unimpaired in 
TLR2
-/-
 DCs; it was nearly absent in MyD88
-/-
 DCs, except for IL-1?? which was 
completely unaffected by MyD88, as had been shown before (30). In contrast, 
Pam2CSK4- and Pam3CSK4-induced cytokine production was dependent on TLR2-
MyD88-signaling (data not shown). At the very early time point of 2h after infection, IL-





 DCs, whereas TNF, IL-1?, and IL-12 were not detectable (data not 
shown). IL-10 was similarly induced by Newman wt and ?lgt in C57BL/6 and TLR2-/- 
DCs after 2h (data not shown).  
We conclude that staphylococcal Lpp selectively trigger the TLR2-MyD88-signaling 
pathway in DCs leading to induction of cytokines. However, our data indicate that in S. 
aureus infection, cytokine production by DCs is also mediated by other MyD88-
dependent signaling receptors.  
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 mice. Neither the deficiency in IL-1R nor in TLR9 affected the 
expression of surface markers on DCs (data not shown). Cytokine responses were as well 
not affected by the absence of these receptors (Figure 2) indicating that other MyD88-
dependent receptors or synergistic/additive stimulation is required for induction of 
cytokines.  
 
Figure 2. MyD88-signaling is independent of S. aureus recognition by IL-1R and TLR9. 




 mice (gray) were infected with S. 
aureus Newman wt for 1h. Fresh medium with gentamicin was added and DCs further incubated 
for 18h. TNF, IL-6, IL-1?, and IL-12 levels in the supernatants of DCs were measured by ELISA. 
Data are represented as mean ± SEM of 3-5 independent experiments. 
 
Phagocytosis of S. aureus by DCs is independent of TLR2-MyD88 
We next wanted to exclude that the amount of engulfed bacteria is responsible for the 
enhanced activation of DC in the presence of Lpp, TLR2 or MyD88. However, 
phagocytosis of Newman wt and ?lgt was similar in DCs from C57BL/6 mice (Figure 3). 
The absence of TLR2 and MyD88 did not influence phagocytosis of both Newman wt 
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and ?lgt suggesting that activation of DCs is enhanced by Lpp-TLR2-MyD88-signaling 
and not by the amount of ingested bacteria.  
 
Figure 3. Phagocytosis of DCs is unaffected by S. aureus Lpp and TLR2-MyD88-signaling. 




 mice were infected with Newman wt (filled) and ?lgt 
(open) for 1h. Extracellular bacteria were killed with lysostaphin and intracellular CFU were 
assessed by plating serial dilutions on MHA plates. Data are mean ± SD of three independent 
experiments. 
 
Lpp-TLR2-MyD88-signaling programs DCs to enhance IFN-? and IL-17 secretion in 
naïve CD4
+
 T cells 
S. aureus primes DCs to promote production of IFN-? and IL-17 in TH cells (21). We 
tested whether Lpp on viable S. aureus Newman are capable of modulating TH1 and 
TH17-cytokines via TLR2 and MyD88. Newman wt-infected C57BL/6 DCs induced 
more IFN-? and IL-17 in naïve CD4+ T cells than ?lgt-infected DCs (Figure 4A). 




 mice revealed that the capacity of 
DCs to enhance IFN-? and IL-17-production in naïve CD4+ T cells resulted from DC 
activation by Lpp, TLR2, and MyD88 (Figure 4A). Infected DCs from all tested mice did 
not induce IL-4 production in naïve CD4
+
 T cells (data not shown) underscoring the 
importance of TH1 and TH17 cells in this bacterial infection. LPS stimulated IFN-? and 
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IL-17 in a MyD88- but not TLR2-dependent manner (Figure 4A). Infected DCs alone or 
T cells alone did not produce any cytokines after S. aureus infection (data not shown). 
Intracellular staining of IFN-? and IL-17 in naïve T cells will elucidate the proportion of 
TH1 and TH17 primed cells (work in progress). Furthermore, DCs from MHC class II
-/-
 
mice will be used to examine the antigen-specific activation of S. aureus and to what 
extend the T cell cytokine production after S. aureus infection in vivo reflects MHC class 
II and TCR engagement (work in progress). 
In addition, we investigated the expression of CD69, an early activation marker of T 




 mice infected with S. aureus Newman 
wt or ?lgt did not cause upregulation of CD69 on naïve CD4+ T cells after 24 and 72h 
(data not shown). 
 
Figure 4. DCs infected with S. aureus promote differentiation of naïve T cells to TH1 and 





 mice (gray) were infected with S. aureus Newman wt and ?lgt for 1h. 
Extracellular bacteria were killed with gentamicin and penicillin/streptomycin and negatively 




 T cells or (B) CD8
+
 T cells were added. Non-infected DCs (nc), and T cells 
only (data not shown) were used as negative controls. LPS was added to non-infected DCs as a 
positive control. Cytokines in the supernatants of cocultures were determined by ELISA after 72h 
of coculture. Data represent mean ± SEM of quadruplicates of one out of two independent 
experiments. C57BL/6-DC infected with wt vs. all other groups*: p<0.05 (Mann-Whitney test). 
 
Lpp-TLR2-MyD88-signaling enhances IFN-? in CD8+ T cells  
S. aureus is known to survive in phagocytes by phagosomal escape (31) and in addition it 
constantly releases proteins during growth (25), which could be taken up by 
micropinocytosis in DCs. Therefore, S. aureus might be able to activate naïve CD8
+
 T 
cells by cross-presentation of peptides on MHC class I. Indeed, S. aureus wt-primed DCs 
from C57BL/6 mice were able to induce the production of IFN-? in naïve CD8+ T cells 
(Figure 4B). In co-cultures of S. aureus wt-infected C57BL/6 DCs with isolated CD8
+
 T 
cells, IFN-? was higher than in cocultures using DC from TLR2-/- and MyD88-/- mice or 
with ?lgt-infected C57BL/6 DCs (Figure 4B). DCs of MHC class I-/- mice and CD4+ T 
cells from transgenic OT-I mice will be used as a control for antigen-specific activation 
of CD8
+
 T cells (work in progress). The data suggest that Lpp-TLR2 interaction and 
MyD88-signaling are required for the activation of CD8
+
 T cells in vitro, possibly by 
cross-presentation of staphylococcal peptides on MHC class I.  
 
T cells produce IFN-? during systemic infection  
To assess whether S. aureus-infected DCs are able to induce T cell activation in vivo, we 




 mice with S. aureus. After 6 days 
of infection, spleen cells were isolated, restimulated with Newman wt and compared to 
  Results – Part 3 
 77
non-stimulated cells in vitro. Restimulated spleen cells from infected C57BL/6 and 
TLR2
-/-
 mice produced high levels of IFN-?, and IL-10, but no IL-4, IL-17 was 
significantly lower in TLR2
-/-
 compared to C57BL/6 cells (Figure 5A). Since we 
previously observed high mortality of Newman wt-infected MyD88
-/-
 mice (9), we used 
the less virulent SA113 wt to investigate spleen cytokine production of infected MyD88
-/-
 
mice. In agreement with results obtained with Newman, SA113 wt induced similar 
quantities of IFN-? ? in restimulated spleen cells of C57BL/6 and TLR2-/- mice; and it 
induced only low amounts in MyD88
-/-
 mice (Figure 5B). IL-10 production after 
stimulation with SA113 wt was partially dependent on TLR2 and completely on MyD88. 
IL-4 production was not detectable (Figure 5B). Intracellular staining revealed that 
numbers of IFN-?- and IL-17-producing CD4+ T cells were 2- to 3-fold higher in infected 
C57BL/6 mice than in non-infected mice (data not shown).  
In summary, after in vivo infection, the effect of Lpp-TLR2 activation upon T cell 
cytokines was not detectable in non-separated spleen cells; it was overridden by other 
signals to MyD88, which strongly contribute to IFN-? and IL-10.  
We sought to examine whether T cells are the major IFN-?-producing cell type of the 





 mice with S. aureus Newman wt to assess the role of B and T 




 mice, Newman wt 
induced less IFN-?, IL-17, and IL-10 than in C57BL/6 spleen cells (Figure 5C). IL-4 was 
only detectable at background level. The data suggest that primarily T cells are 
responsible to mount a strong cytokine response against S. aureus. Next, we used MuMt
-/-
 
mice to evaluate the contribution of B versus T cells in S. aureus infection. Compared to 
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C57BL/6 spleen cells, restimulated spleen cells of MuMt
-/-
 mice produced 6-, 7- and 17- 
fold more IFN-?, IL-17, and IL-10 in response to Newman wt, respectively (Figure 6C). 
Taken together, the results indicate that T cells are the major IFN-?-producing cell type 
and that B cells regulate the production of the cytokines by T cells. The direct or indirect 
control of IFN-? production by B cells will be investigated by measuring IFN-? in 
infected spleen cells from MuMt
-/-
 mice after costimulation with purified C57BL/6 B 
cells (work in progress). It will be further evaluated whether the interaction of B with T 
cells needs cell-cell contact and leads to transcriptional downregulation of IFN-? and IL-
17 mRNA.  
 
Figure 5. T cells are produce IFN-?  and IL-17 during S. aureus infection. (A, B) C57BL/6 
(black), TLR2
-/-
 (white), and MyD88
-/-
 mice (gray) were i.v. infected with S. aureus Newman or 




 (white), and MuMt
-/-
 mice (striped) were 
i.v. infected with S. aureus Newman wt. (A–C) After 6 days of infection, spleen cells were 
isolated and restimulated with Newman wt or SA113 wt (MOI 1) for 1h. Bacteria were killed 
with gentamicin and penicillin/streptomycin and cells were further incubated for 48h. Cytokines 
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in the supernatant were analyzed by ELISA. Data are represented as mean ± SEM of 
quadruplicates of 4 mice per group. C57BL/6 vs. all other groups, *: p<0.05, ***: p<0.001 
(Mann-Whitney test). 
 
Adaptive immune cells do not contribute to killing of S. aureus in early sepsis 
We aimed to elucidate whether T and/or B cells are beneficial for outcome and contribute 







 mice infected with an inoculum of Newman wt, which was 
sublethal in C57BL/6 mice (9), was not affected in these mice (data not shown). Weight 
loss of MuMt
-/-





 mice was significantly lower than in C57BL/6 mice after 2 and 6 days 







 mice was lower than in C57BL/6 mice; also in liver and kidneys bacterial numbers were 
slightly, but not significantly lower in the immunocompromised compared to C57BL/6 
mice (Figure 6B). Plasma IL-6 levels were significantly lower on day 6 and kidney 






 mice compared to C57BL/6 mice 
(Figure 6C). These data indicate that the innate immune response is required for 
staphylococcal defense, whereas the adaptive immune response mediated by T cells and 
B cells is not beneficial for eradication of S. aureus in early murine sepsis.  
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Figure 6. Absence of adaptive immune cells enhances killing of S. aureus in mice. C57BL/6 
(black, solid line), Rag2
-/-
 mice (white, dashed line), CD3
-/-
 (gray, dotted line), and MuMt
-/-
 mice 
(half filled, dash-dotted line) were infected with Newman wt. (A) Weight loss, (B) bacterial load 
in spleen, liver, both kidneys, and both knees, and (C) plasma IL-6 in mice on day 6. Data for 
mice are represented as mean ± SD for weight loss and cytokines and median for CFU/mg of 3-7 
mice per group. Significant differences between mice are indicated by *: p<0.05, **: p<0.01, and 
***: p<0.001. 
In the above studies, we selected a sublethal inoculum and followed sepsis during 7 days. 
During this acute phase, we found T and/or B cells disadvantageous. Next, we were 
interested into their role in persistence. To that aim, we examined the ability of innate and 
adaptive immune cells to eradicate S. aureus in chronic infection. Thus, we monitored 
mice for 28 days after infection with the low-virulent SA113 wt strain in C57BL/6 
(Figure 7) and Rag2
-/-
 mice (work in progress). Notably, although infected C57BL/6 mice 
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regained weight (Figure 7A), not all were able to clear S. aureus SA113 from liver, 
kidneys, and knees (Figure 7B).  
 
Figure 7. Innate and adaptive immune cells do not eradiate S. aureus from organs. C57BL/6 
mice were infected with SA113 wt (black) for 28 days. NaCl was injected in control mice (gray). 
(A) Weight loss, (B) bacterial load in blood, liver, both kidneys, and both knees on day 28. Data 
for mice are represented as mean ± SD for weight loss and cytokines and median for CFU/mg of 
5 mice. 
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Discussion  
In this report, we show for the first time that staphylococcal Lpp expressed on viable S. 
aureus enhance the activation of DCs by TLR2 and thereby promote the differentiation of 
naïve CD4
+
 T cells into TH1 and TH17 cells in vitro. We further demonstrate that in vivo 
in whole spleen cells the contribution of Lpp-TLR2 to IFN-? production is mitigated by 
other MyD88-signaling receptors, while Lpp-TLR2-dependence remains detectable for 
IL-10 and IL-17. We then provide evidence that beside TH cell differentiation, S. aureus-
infected DCs that receive Lpp-TLR2 signals are competent to activate CD8
+
 T cells to 
produce IFN-?. Finally, we show that T cells are the major producers of IFN-?, IL-17, 
and IL-10 after systemic S. aureus infection, and B cells negatively regulate these T cell 
cytokines. Surprisingly, one week after infection, T and/or B cells do not improve 
outcome, but impair the killing of S. aureus from the organs.  
The innate immune response to S. aureus is primary during acute invasive infections. 
However, it is well known that S. aureus also activates the adaptive immune response 
with its superantigens, yet the incidence of superantigen-related toxic shock syndrome is 
low. This is possibly due to the fact that S. aureus downmodulates the T cell response to 
these superantigens (32), which was recently shown to be related to the release of cell 
wall components that preferentially activate the anti-inflammatory axis of the adaptive 
immune system (33). The contribution of superantigens to sepsis is controversial and 
mostly believed to be due to general inflammation. However, the regulation of the 
antigen-specific T cell polarization and on B cell responses as well as the effect of T and 
B cells upon outcome in acute S. aureus sepsis is not clear yet. Previous studies on the 
activation of T cells have used purified staphylococcal molecules, but not viable S. 
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aureus. To close the gap, we evaluated the requirements for S. aureus and for the host to 
promote the activation of T cells and more importantly, the differentiation of T cells into 
TH1, TH2, or TH17 lineages.  
The expression of surface markers e.g. CD40 is required for contact of DCs with T cells 
to induce inflammatory cytokines. It has been shown that TLR2 on DCs increased 
expression of MHCII and CD80 after stimulation with staphylococcal PGN (34). We now 
demonstrate that Lpp present in viable S. aureus are modestly contributing through the 
activation of the TLR2 pathway to induce the upregulation of the surface marker CD40, 
CD80, and CD86. In contrast, the MHC class II molecule was strongly upregulated after 
infection with S. aureus, but independent of MyD88-signaling as demonstrated 
repeatedly for LPS (own data and (35)). There is however controversy whether signals 
from TLRs can regulate phagosome maturation and hence phagosomal processing and 
presentation. Blander and Medhzitov demonstrated that apoptotic cells or particulate Ags 
are only presented efficiently by MHC class II in DCs when they are associated with a 
TLR ligand (36). In contrast, Russell and coworkers demonstrated that TLR2- or TLR4-
agonists did not affect phagosome maturation (37). 
DCs infected with viable S. aureus released TNF, IL-6, IL-10, IL-1?, and IL-12. 
Surprisingly, although viable S. aureus are recognized by various PRRs, in our 
experiments the activation of DCs was mostly dependent on Lpp-TLR2-signaling and not 
on other MyD88-dependent receptors. Nevertheless, some cytokines were induced by S. 
aureus in the absence of TLR2 but not MyD88. In contrast, TLR2 was essential only for 
the response to purified streptococcal components, while whole Streptococcus gordonii 
elicited similar levels in C57BL/6 and TLR2
-/-
 cells (38). However in line with our 
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results, cytokine induction by live streptococci and by its purified PAMPs was dependent 
on functional MyD88. In our study, the recognition of staphylococcal DNA by TLR9 and 
the sensing of IL-1 by its receptor IL-1R had no impact on the released cytokines. 
Therefore, it remains to be elucidated, whether other MyD88-dependent signaling 
receptors, like the bacterial RNA-sensing TLR7 (14), or TLR4, which activates DCs after 
exposure to staphylococcal leukocidin, are involved (39). Alternatively, the number of 
engulfed bacteria can affect the cytokine production in cells, which can be excluded since 
DCs without TLR2 and MyD88 phagocytosed similar numbers of S. aureus.  
TLR stimulation of DCs induces TH1, TH2, or TH17 responses depending on the 
expression of cytokines. IL-12 mediates the differentiation of naïve T cells into IFN-? 
producing TH1 cells. Indeed, the high levels of IL-12 released in a Lpp-TLR2-dependent 
fashion in DCs may have contributed together with MHC-TCR interaction to IFN-? 
production by naïve T cells. IL-4 was absent, which may be related to the suppressive 
effect of IFN-? on TH2 development (41). Low levels of IL-17 were detected. This 
finding is surprising, first, because IFN-? inhibits the differentiation of TH17 cells and 
alters the cytokine profile of DCs to reduce IL-17 by limiting IL-23 release (42, 43, 44). 
Second, the Lpp-TLR2-MyD88 pathway activated by S. aureus was found associated 
with a reduced proportion of IL-17 secreting CD4
+
 T cells, at least in immune cells 
associated with a brain abscess (45). Yet, the production of IL-17 may have been 
supported by high quantities of the proinflammatory cytokine IL-6, possibly together 
with TGF-? and amplified by high levels of TNF and IL-1? in DCs (46).  
We found high levels of IFN-? produced by C57BL/6 CD4+ T cells after S. aureus wt 
infection. Superantigens were unlikely contributing to this effect, since infection of 






 cells with the same superantigens-expressing S. aureus strain 
resulted in a reduced IFN-? response. However, it remains to be documented that the ?-




 cells before participation of 
superantigens in IFN-? production can be ruled out.  
We found IFN-? production by CD8+ T cells upregulated by Lpp-TLR2. Endocytosis of 
released antigens from the surface of S. aureus during growth or after antibiotic treatment 
and crosspresentation on MHC class I may have enabled infected DCs to activate CD8
+
 T 
cells. Additionally, survival of S. aureus within DCs and escape from the intracellular 
compartment by hemolysin-mediated membrane rupture (31) or the release of antigens 
into the cytoplasm may have lead to the activation of cytotoxic T cells. In a superantigen-
mediated lung disease model, CD8
+
 T cell-derived IFN-? was found responsible for 
pulmonary pathology (47), but so far, the effect of CD8
+
 T cells on the pathogenesis of 
systemic S. aureus infection is unclear. Interestingly in LCMV infection, MyD88 
expression in T cells is required for an intact primary CD8
+
 T cell response (48) and 
TLR2 engagement is required for an effective anti-tumor CD8
+
 T cell response (49). 
However, S. aureus did not elicit IFN-? production in naïve purified T cells after 
infection. Therefore, in our study, a Lpp-stimulation of TLR2 on CD8
+
 T cells does not 
explain the MyD88-mediated regulation of IFN-? from these cells.  
After S. aureus infection of mice, restimulated spleen cells elicited both IFN-? and IL-10 
responses independent of TLR2-signaling, but dependent of MyD88. We had previously 
found a highly impaired cytokine induction in MyD88-deficient macrophages (9). We 
and others found this lack of cytokines associated with a higher susceptibility to sepsis of 
MyD88
-/-
 mice (9-12). The present report extends the findings to DCs, which apparently 
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also contribute to immune defense through T cell activation. It is however surprising that 
MyD88 is such a strong regulator of the IFN-?, ?IL-17, and IL-10? response in CD4+ and 
CD8
+
 T cells. Since a MyD88 effect upon T cell numbers and spleen size was excluded 
to viable S. aureus, the antigen-driven response appears determined by MyD88 
costimulation. Infection of MHC class II negative mice will inform on the relative 
contribution of MHC class II-TCR interaction to IFN-? from spleen cells ex vivo. For 
Toxoplasma gondii proteins, which act through TLR11-MyD88, it was recently shown 
that MHC class II has to be expressed together with MyD88 in DC in order to elicit an 
IFN-? response in CD4+ T cells (50). In agreement with our in vitro results, the low 
TLR2-MyD88-dependent release of IL-17 was also observed ex vivo and may be related 
to the previously described pronounced TLR2-dependent IL-6 production in restimulated 
spleen cells of Newman-infected mice (9).  
We could assign S. aureus-induced IFN-? production to T cells, since we detected 
significantly less IFN-? in spleens from S. aureus-infected CD3-/- mice and hardly any 
IFN-? in those from Rag2-/- mice. Surprisingly, B cells had a suppressive function on T 
cell derived IFN-?, IL-10, and IL-17 as we concluded from the excessive cytokine levels 
produced by B cell-deficient spleen cells from MuMt
-/-
 mice. Since the spleen weight, the 
number of mononuclear cells and CD4
+
 T cells in the spleens of MuMt 
-/-
 mice are less 
than 10% of the number observed in the spleens of C57BL/6 mice (51), the high IFN-? 
cannot be due to an altered T cell number. It remains to be investigated, whether B cells 
reduce IFN-? in C57BL/6 mice because S. aureus is better opsonized and elicits less 
immune activation or whether there is a direct inhibition of a B cell molecule or product 
upon T cells.  
  Results – Part 3 
 87
Several studies using the septic arthritis model in S. aureus infection, revealed that the 
IFN-? dominated immune responses are beneficial for the outcome of mice (18-20). In 
view of the high IFN-? in MuMt-/- mice, we expected a better outcome of infection in 
these mice. B cell deficiency was beneficial for control of S. aureus; however, we found 
no correlation of IFN-? levels and bacterial load, since CD3-/- and Rag2-/- mice with low 
or no IFN-? showed accelerated or improved clearance of S. aureus from the organs. The 
low bacterial load in the mice lacking B and T cells correlated with the absence of 
infiltrates and lower IL-6 levels in plasma as an indicator for disease severity. These 
results are in line with our earlier report of a similar liver pathology in mice deficient in 
MyD88-signaling (9). In these mice, we could relate the better killing of S. aureus to the 
lack of chemokines and phagocyte recruitment, which prevented bacterial hiding in the 
liver and facilitated access of resident phagocytes to S. aureus. Here we show that T and 
or B cells did not improve the outcome after 6 days of systemic S. aureus infection. It 
was rather worsened, most likely through the inflammation, which is amplified by these 
cells. Four weeks follow up of the outcome in C57BL/6 and Rag2
-/-
 mice will inform on 
whether a functional adaptive immune system at a later time point improves bacterial 
clearing.  
Taken together, although MyD88-mediated immune responses favor the outcome after S. 
aureus infection (9), the host is unable to control S. aureus infection by both innate and 
adaptive immune systems until differentiation and expansion and of T and B cells into 
effector cells occurs. 
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3.4 Part 4 – Role of TLR9 and NOD2 in sensing of S. aureus 
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Introduction 
Receptors of the innate immune system have evolved for the recognition of different 
conserved microbial features, so called PAMPs, to detect the presence of pathogens. 
S. aureus expresses various PAMPs, which interact with TLRs and NOD2, respectively. 
Several studies investigated the role of individual receptors in sensing of isolated 
PAMPs.  
TLR2 detects several components of the S. aureus cell wall preferentially lipoproteins (1-
3); TLR4 might interact with leukocidin (4); TLR7 and TLR9 recognize RNA and DNA, 
respectively (5); IL-1R senses endogenous IL-1 released by activated cells after S. aureus 
infection (6). In addition to TLR receptors, NOD2 senses the peptidoglycan subfragment 
muramyl dipeptide (MDP) from S. aureus (7) in the cytoplasm. However, few studies 
have addressed the question whether these receptors trigger similar responses when 
stimulated with viable S. aureus. Recognition of whole bacteria can initiate signaling by 
both extracellular TLRs and intracellular TLRs and NODs. Accordingly, TLR2 and 
NOD2 have a dual role in activation of cytokine responses and defense against S. aureus; 
they can be either protective (8-10) or detrimental (11).  
In the previous three parts, we showed that in response to S. aureus, macrophages from 
MyD88
-/-
 mice fail to produce proinflammatory cytokines including TNF, and animals 
exhibit an increased susceptibility (1, 2). On the other hand, TLR2
-/-
 macrophages 
produce normal levels of TNF at later stages in infections and TLR2
-/-
 mice do not 
display the severe phenotype of MyD88
-/-
 mice (1, 2) suggesting a contribution of 
intracellular TLRs and MyD88-dependent cytokine receptors. Therefore, we asked the 
question whether TLR9 and IL-1R contribute to the host responses induced by S. aureus. 
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Furthermore, we and others showed that S. aureus gains access to the cytoplasm (12, 13) 
and thus we postulated a role for NOD2.  
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Material and Methods 
Stimulation of macrophages 











were infected with the S. aureus strain SA113 as described in Material and Methods in 
Part 1. 
 











 mice were i.v. infected with 
1 x 10
7
 CFU of SA113 wt as described in Material and Methods in Part 1. 
 
Statistical analysis 
Statistical analyses of cytokines, CFU in organs, cytokines in plasma were analyzed with 
Mann-Whitney. 2-way ANOVA was used to analyze weight loss of mice in systemic 
infections. Statistical analysis was done with Prism 5.0a (GraphPad Software, Inc.). A p-
value of p <0.05 was considered statistically significant. 
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Results 
IL-1R and TLR9 in S. aureus infections  
To assess the role of IL-1R and TLR9 in inflammatory responses to viable S. aureus 










 macrophages (Figure 1A). While cytokine and chemokine 
levels of IL-1R
-/-
 macrophages were similar to those induced in C57BL/6 macrophages, 
levels of all cytokines, but not of MIP-2, were decreased in TLR9
-/-
 cells (Figure 1A). 
These data show that TLR9 but not IL-1R contributes to induction of inflammatory 
responses after S. aureus infection.  
 
 
Figure 1. TLR2 and TLR9 enhance cytokine production of macrophages in S. aureus 





and (B) C57BL/6 (black), TLR2/9
-/-
 (striped), and MyD88
-/-
 (dotted) were infected with SA113 
wt at MOI 10. TNF, IL-6, IL-10, IL-1?, and MIP-2 released into the supernatants were analyzed 









 cells are indicated as follows: *, p < 0.05; **, p < 0.01, ***, p < 0.001.  
 
We next investigated whether the lack of TLR2/9 abolishes cytokine production to levels 
observed with MyD88
-/-
 macrophages (described in Part 1). In response to S. aureus, both 






 macrophages released significantly less of the measured 
cytokines compared to C57BL/6 cells (Figure 1B). Whereas MyD88
-/-
 macrophages 
released no TNF and IL-6, responsiveness in TLR2/9
-/-
 macrophages was impaired but 
not abolished (Figure 1B). IL-10 and IL-1? were released neither by MyD88-/- nor 
TLR2/9
-/-
 macrophages. MIP-2 was not dependent on TLR2/9-signaling but on MyD88 
(Figure 1B). These data suggest that both TLR2 and TLR9 have to be activated by S. 
aureus to induce an efficient cytokine response in macrophages. However, other MyD88-
dependent receptors beyond TLR2 and TLR9 seem to be involved in the induction of 
TNF, IL-6, and MIP-2. 
To elucidate the contribution of TLR9 in vivo, we systemically infected TLR9
-/-
 mice 
with SA113 wt and compared them to C57BL/6 mice. The absence of TLR9 did not 
affect weight loss (Figure 2A). Bacterial load in spleen, kidneys, and knees was similar, 
but reduced in the liver of TLR9
-/-
 mice (Figure 2A). Reduced levels of IL-6 in plasma 
correlated with less infiltrates in the liver of TLR9
-/-
 mice (Figure 2A). These results 
suggest that in systemic infection, recognition of staphylococcal DNA by TLR9 is not 
relevant for killing of S. aureus, but required for the attraction of phagocytes and 
inflammation. 
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Figure 2. Concurrent signaling by TLR2 and TLR9 is required for virulence of S. aureus. 
(A) C57BL/6 (black) and TLR9
-/-
 mice (white) and (B) C57BL/6 (black), TLR2/9
-/-
 (gray), and 
MyD88
-/-
 mice (white) were infected with 1 x 10
7
 CFU of SA113 wt. Weight loss of mice was 
measured during infection and bacterial load in spleen, liver, both kidneys, and both knees, IL-6 
amounts in plasma, and number of infiltrates in the liver was determined on day 8. Significant 
differences between (A) C57BL/6 and TLR9
-/-




 mice are 
indicated as follows: *, p < 0.05; **, p < 0.01, ***, p < 0.001.  
 









 mice also had higher bacterial load in liver, kidneys, and knees, 






 mice had more bacteria in the liver, but less in 
kidneys and knees; IL-6 in plasma was lower, whereas infiltrates were more numerous in 
TLR2/9
-/-
 mice (Figure 2B). Interestingly, the phenotype of TLR2/9
-/-
 mice strikingly 
resembled the TLR2
-/-
 phenotype (see Part 1, Figure 3). Taken together, our data suggest 
that TLR2 is more important than TLR9, and TLR2/9
-/-
 mice are not as susceptible to 
S. aureus as MyD88
-/-
 mice.  
 
Role of MyD88-independent receptors recognizing Peptidoglycan motifs 
To assess the contribution of NOD2 to the release of inflammatory mediators, we 
infected NOD2
-/-
 macrophages with S. aureus SA113 wt. NOD2
-/-
 macrophages showed 
diminished ability to release TNF, IL-6, IL-10, and IL-1? but not MIP-2 (Figure 3A) 
indicating that NOD2 is a crucial receptor to establish a strong inflammatory immune 
response after S. aureus infection.  
After infection of NOD2
-/-
 mice with S. aureus SA113 wt, weight loss of NOD2
-/-
 mice 
was comparable to C57BL/6 mice during infection (Figure 3B). Bacterial load was lower 
in liver but not in spleen, kidneys, and knees of NOD2
-/-
 than of C57BL/6 mice (Figure 
3B). In the absence of NOD2-signaling, IL-6 in plasma was lower and infiltrates were 
less numerous in the liver (Figure 3B). Similar to the results of TLR9
-/-
 mice, NOD2 does 
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not contribute to weight loss and bacterial killing in most organs, but is necessary for 
recruitment of inflammatory cells and cytokines.  
 
 
Figure 3. Signaling by NOD2 is required for virulence of S. aureus. (A) Peritoneal 
macrophages from C57BL/6 (black) and NOD2
-/-
 (gray) were infected with SA113 wt at MOI of 
10. TNF, IL-6, IL-10, IL-1?, and MIP-2 released into the supernatants were analyzed by ELISA 
after 18h. Significant differences between groups are indicated as follows: *, p < 0.05; **, p < 
0.01, ***, p < 0.001. (B) C57BL/6 (black) and NOD2
-/-
 mice (white) were infected with 1 x 10
7
 
CFU of SA113 wt. Weight loss of mice was measured during infection and bacterial load in 
spleen, liver, both kidneys, and both knees, IL-6 amounts in plasma, and number of infiltrates in 
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the liver was determined on day 8. Significant differences between groups are indicated as 
follows: *, p < 0.05. 
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Discussion 
Distinct PRRs can cooperate to detect different ligands with converging signaling 
pathways. TLRs and IL-1R contain an intracellular TIR-domain to which MyD88 is 
recruited (except TLR3) for signal transduction via NF-?B. Activation of more than one 
MyD88-dependent receptor might have an impact on the expression of many immune and 
inflammatory genes. In S. aureus infection models, the role of TLR2 and MyD88 has 
been established (1, 2, 6, 14-16), but the function of other TIR-domain receptors 
contributing to the phenotype of MyD88
-/-
 mice are not clearly understood. Additionally, 
the use of different strains of S. aureus complicates the interpretation of the results.  
 
In the present part, we have analyzed the contribution of IL-1R, TLR9, and NOD2 in 
sensing of staphylococcal components and in inducing a host response after infection of 
macrophages and mice. We demonstrate that cytokine induction in macrophages is 
mediated by TLR9 and NOD2 but not by IL-1R. The phenotype of the MyD88
-/-
 mice 
after S. aureus infection is partially dependent on the concurrent signaling of TLR2 and 
TLR9, but other receptors signal in addition through MyD88 to initiate cytokine 
responses in vitro. Surprisingly, in systemic infections, the importance of TLR9, TLR2/9, 
and NOD2 in defense against S. aureus is less evident.  
 
The inflammatory cytokines like TNF, IL-6, IL-1?, the anti-inflammatory cytokine IL-
10, and chemokine MIP-2 are critical mediators in systemic infections (17). They are 
induced after infection of macrophages with viable S. aureus in a MyD88-dependent 
fashion (1). We found however no influence of IL-1R-signaling upon the production of 
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these mediators in macrophages. In line with our observation, heat-killed S. aureus 
induced TNF in macrophages without altering the cytokine production in the presence of 
an IL-1R agonist (10). In subcutaneous infection, IL-1R
-/-
 mice showed similar levels of 
IL-1?, MIP-2, and KC after 24h (6). In contrast, IL-1R protected the host from 
uncontrolled growth of S. aureus in organs preventing the development of severe sepsis 
and arthritis after systemic infections (18).  
We demonstrate that TLR9 was required for optimal induction of all cytokines except 
MIP-2. This finding contrasts with a recent study showing that heat-killed S. aureus 
stimulates macrophage-cytokines independent of TLR9 (10). This discrepancy might be 
due to the fact that heat-killed S. aureus present altered or other PAMPs to PRRs than 
viable bacteria. In addition, viable S. aureus need first to be engulfed and degraded to 
activate PRRs in the phagosome, whereas heat-killed bacteria also activate surface-
expressed PRRs. However, in line with our data, the TLR9-effect upon the inflammatory 
response was also evident by the reduced plasma IL-6 level and low number of infiltrates 
in TLR9
-/-
 mice after systemic infection. The data suggest that DNA activation of TLR9 
provides strong signals for acute phase response and leukocyte recruitment to mount a 
robust immune response against S. aureus. Surprisingly, the reduced inflammatory 
response in TLR9
-/-
 mice did not result in impaired killing of S. aureus in systemic 
infection (this study), which is in agreement with data from a corneal infection model 
(16).  
TLR2 and TLR9 activate cytokine responses through the central adapter MyD88, which 
is essential for production of proinflammatory cytokines (1, 2). Reduction in cytokine 
amounts in TLR2/9
-/-
 macrophages give evidence that recognition of Lpp and DNA from 
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S. aureus trigger MyD88-dependent signaling pathways that partially explain the 
phenotype of MyD88
-/-
 mice. However, TLR2/9
-/-
 macrophages did not fail to produce 
cytokines and mice were not as susceptible as MyD88
-/-
 mice suggesting that beside 
TLR2 and TLR9 other unknown MyD88-dependent receptors are involved in vitro and in 
vivo. One candidate is TLR7, which was not yet investigated in S. aureus infections. 
However, in vitro experiments showed the importance of bacterial RNA recognition (5, 
19). Additionally, studies with multiple knock-out mice were not yet done.  
NOD2 as an intracellular receptor for detection of MDP from several bacteria is also 
involved in the recognition of staphylococcal PGN or S. aureus (7-10). In agreement with 
reduced IL-6 levels in BMM (9), we found that macrophages infected with viable S. 
aureus were highly impaired in the production of proinflammatory and anti-inflammatory 
cytokines suggesting that intracellular NOD2 recognizes S. aureus fragments in the 
cytoplasm. To date we know that staphylococcal hemolysins and ATP facilitate 
intracellular delivery of MDP to cytosolic NOD2 (20) but the exact pathway of MDP 
delivery remains elusive. Furthermore, reduced amounts of IL-1? in S. aureus-infected 
NOD2
-/-
 macrophages suggested that processing of pro-IL-1? to active IL-1? was 
impeded. Indeed, a recent study showed that MDP-induced caspase-1 activation via 
NLrp3 resulted in processing of IL-1? (20). In previous studies using subcutaneous and 
peritoneal S. aureus infection, NOD2
-/-
 mice were more susceptible, which was 
associated with higher bacterial load (8, 9) and lower inflammatory responses (9). Since 
both models are dependent on the attraction of cells, an impaired inflammatory response 
might influence survival of S. aureus in the absence of NOD2. In systemic infection, we 
found NOD2 required for the IL-6 response and recruitment of inflammatory cells, 
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although it did not affect the outcome. The lower bacterial load in the liver of NOD2-/- 
mice might be explained by reduced leukocyte infiltrates that allowed immune cells 
better accessibility to kill S. aureus (1).  
In conclusion, S. aureus present a wide variety of PAMPs that phagocytes recognize by 
PRRs. No single receptor, as shown for TLR2, TLR9, and NOD2, is the sole mediator of 
a protective immune response, whereas signaling by the MyD88-adaptor is essential. 
Future studies will help to understand synergism and crosstalk of different PRRs and 
provide a new basis for identification of new therapeutic targets. 
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4 Perspectives 
We undertook our studies on S. aureus Lpp to understand their pathogenetic role in 
staphylococcal infection and to uncover their potential use as therapeutic target.  
More and more variants of S. aureus have developed resistance against available 
antibiotics (78). MRSA is the most common cause of nosocomial infections; community-
associated MRSA strains can spread rapidly among healthy individuals and have now 
been transmitted in hospitals (79, 80). The exposure of community-associated MRSA to 
nosocomial strains may lead to untreatable S. aureus infections due to horizontal gene 
transfer and antibiotic pressure, which will encourage the emergence of multiple 
resistances (78, 80). Therefore, the major task is to understand the interaction of S. aureus 
and the host to develop new preventive and therapeutic strategies including antibiotics 
and vaccines. Furthermore, the identification of new therapeutical targets is indispensible.  
 
Colonization is a complex process that requires nutrient acquisition, adherence to the host 
tissue, and protection against host defenses. Since colonization is a risk factor for 
systemic infection (2, 3), reducing the fitness of S. aureus by therapeutic agents might 
prevent colonization and more importantly invasion. As shown in part 1, Lpp maturation 
enhances the fitness of S. aureus by enhancing iron acquisition. Blocking the Lgt enzyme 
leads to a stronger release of non-mature Lpp and an impaired iron uptake of S. aureus 
(58). Indeed, we were able to show that the intrabacterial iron content has dramatic 
consequences for S. aureus; survival and growth of iron-restricted S. aureus were 
significantly reduced causing a less severe infection. Our data are supported by another 
  Perspectives 
 112
study showing that S. aureus deficient in the Lpp-containing ABC-transporter (Isd) 
display an attenuated phenotype during infection (81). Therefore, most likely the 
acquisition of iron is also required in the nasopharynx for successful colonization and 
infection. After successful colonization or adhesion, S. aureus can invade to gain access 
to the large reservoir of substrates within the host. We demonstrated that maturation of 
Lpp enhances the invasive capacity of S. aureus. This suggests that blocking the 
maturation of Lpp might also prevent the crossing of physical barriers. Further 
experiments will elucidate the need of Lpp maturation in S. aureus for invasion and 
uptake of other nutrients such as amino acids and metals in competition with commensals 
and the host. 
Besides nutrient acquisition, Lpp allow the detection of S. aureus by TLR2, which 
induces leukocyte recruitment to the local site of infection. A recent study showed that a 
neutrophil-rich environment favors staphylococcal survival in wound infections (82) 
supporting that a too strong immune response is harmful for the host. This raises the 
question whether preventing Lpp-TLR2-signaling on the host side would be a potential 
approach in therapy. However, deficiencies in TLR2 and IL-17 facilitate the colonization 
of S. aureus, which might be due to impaired induction of neutrophil chemoattractants 
and ?-defensins in epithelial cells (60, 83). From this perspective, blocking TLR2 might 
be the wrong approach. In contrast, inactivation of the Lgt enzyme would reduce, but not 
abolish TLR2-signaling due to residual stimulation by LTA and PGN and allow 
maintaining a well-balanced recruitment of cells to protect the mucosa. 
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In contrast to local infection, TLR2 blockage might be a therapeutic option in systemic 
infection. S. aureus activates several receptors including TLR2, TLR9, and NOD2 for 
signaling through NF-?B. The activation of NF-?B has a central role in the generation 
and expansion of the inflammatory response and the development of organ dysfunction 
(84). In addition to the exogenous stimuli, endogenous DAMPs such as alarmins (85) are 
released during sepsis (86). As a consequence of the overstimulation of immune cells, 
beneficial immune responses convert into excessive, damaging inflammation (86). Septic 
shock induced by bacterial lipopeptides was found to be dependent on TLR2 (87) while 
toxic effects of CpG-DNA are mediated by TLR9 (35). Therefore, targeting TLRs is 
promising in the treatment of sepsis. This assumption is sustained by two TLR4-
antagonists for treatment of severe Gram-negative sepsis (TAK-242 and Eritoran, clinical 
Phase III) (27), which bind to TLR4 but do not induce signaling. Similarly, the synthesis 
of TLR2 antagonists preventing overstimulation of the host might be beneficial for 
patients with S. aureus sepsis. 
The type of primary T cell response and the proportions of IFN-? producing TH1 cells and 
IL-17-producing TH17 cells respectively may also determine the outcome of S. aureus 
infection. We observed an Lpp-TLR2-dependent recruitment of myeloid cells into the 
liver. However, in this organ a moderate immune response is required for maximal S. 
aureus killing, since large numbers of abscesses and infiltrates hamper bacterial killing. 
We further demonstrated a TLR2-MyD88-dependent IL-17 release from infected spleen 
cells during infection. Taking into account that IL-17 attracts granulocytes (55, 83) and 
that enhanced neutrophil recruitment improves staphylococcal survival in infected 
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wounds (82), it remains to be investigated whether a modulation of TH17 activity is 
beneficial for the host.  
Another approach in S. aureus treatment is the induction of memory responses. Whether 
Lpp-TLR2-signaling after S. aureus infection promotes differentiation toward memory 
immune cells is an open question. Recent data show that injection of staphylococcal Lpp 
is protective against challenge with S. aureus in a colonization and invasion model 
(Gordon Conference, 2009 and ISSSI, 2006). It is noteworthy that on the one hand, Lpp 
are able to stimulate TLR2 in the phagosome and on the other hand, Lpp-derived peptides 
can be presented on MHC molecules. Both signals result in a more efficient presentation 
of antigens to CD4
+
 T cells. Whether DC-dependent instruction of T cells is helpful for B 
cells and which type of antibodies is protective is focus of future studies. Furthermore, 
the exact mechanism of antibody-mediated protection has to be resolved, since Lpp are 
anchored in the membrane and antibodies are not able to cross the bacterial cell wall.  
The protective effect of Lpp as described above was mediated by injection of selected 
Lpp. Whether other Lpp confer better protection remains to be elucidated. To understand 
the role of individual Lpp, it is important to determine what Lpp are expressed during 
infections. A group investigated the mRNA expression of Lpp under normal growth 
conditions in vitro (88). The next step is to change the growth conditions to predict 
possible functions of Lpp and to characterize their expression in infection. 2D-gel 
electrophoresis would be an ideal tool to analyze individual Lpp of S. aureus. The Lpp 
expressed under in vivo conditions will be the most promising Lpp to combine in a 
vaccine.  
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Our studies demonstrated the contribution of Lpp to the pathogenesis of staphylococcal 
diseases and will greatly assist future strategies for prophylactic or therapeutic 




  References 
 117
5 References 
1. Feil, E.J., J.E. Cooper, H. Grundmann, D.A. Robinson, M.C. Enright, T. Berendt, 
S.J. Peacock, J.M. Smith, M. Murphy, B.G. Spratt, C.E. Moore, and N.P. Day. 
2003. How clonal is Staphylococcus aureus? J Bacteriol 185:3307-3316. 
2. Peacock, S.J., I. de Silva, and F.D. Lowy. 2001. What determines nasal carriage 
of Staphylococcus aureus? Trends Microbiol 9:605-610. 
3. von Eiff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal 
carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J 
Med 344:11-16. 
4. Lindsay, J.A., and M.T. Holden. 2004. Staphylococcus aureus: superbug, super 
genome? Trends Microbiol 12:378-385. 
5. Cheung, A.L., S.J. Projan, and H. Gresham. 2002. The Genomic Aspect of 
Virulence, Sepsis, and Resistance to Killing Mechanisms in Staphylococcus 
aureus. Curr Infect Dis Rep 4:400-410. 
6. Karauzum, H., T. Ferry, S. de Bentzmann, G. Lina, M. Bes, F. Vandenesch, M. 
Schmaler, B. Berger-Bachi, J. Etienne, and R. Landmann. 2008. Comparison of 
adhesion and virulence of two predominant hospital-acquired methicillin-resistant 
Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus 
isolates. Infect Immun 76:5133-5138. 
7. Navarre, W.W., and O. Schneewind. 1999. Surface proteins of gram-positive 
bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol 
Mol Biol Rev 63:174-229. 
8. Maresso, A.W., and O. Schneewind. 2008. Sortase as a target of anti-infective 
therapy. Pharmacol Rev 60:128-141. 
9. Sankaran, K., S.D. Gupta, and H.C. Wu. 1995. Modification of bacterial 
lipoproteins. Methods Enzymol 250:683-697. 
10. Hutchings, M.I., T. Palmer, D.J. Harrington, and I.C. Sutcliffe. 2009. Lipoprotein 
biogenesis in Gram-positive bacteria: knowing when to hold 'em, knowing when 
to fold 'em. Trends Microbiol 17:13-21. 
11. Stoll, H., J. Dengjel, C. Nerz, and F. Götz. 2005. Staphylococcus aureus deficient 
in lipidation of prelipoproteins is attenuated in growth and immune activation. 
Infect Immun 73:2411-2423. 
12. Tawaratsumida, K., M. Furuyashiki, M. Katsumoto, Y. Fujimoto, K. Fukase, Y. 
Suda, and M. Hashimoto. 2009. Characterization of N-terminal structure of 
TLR2-activating lipoprotein in Staphylococcus aureus. J Biol Chem  
13. Kurokawa, K., H. Lee, K.B. Roh, M. Asanuma, Y.S. Kim, H. Nakyama, A. 
Shiratsuchi, Y. Choi, O. Takeuchi, H.J. Kang, N. Dohmae, Y. Nakanishi, S. 
Akira, K. Sekimizu, and B.L. Lee. 2009. The triacylated ATP binding cluster 
transporter substrate-binding lipoprotein of Staphylococcus aureus functions as a 
native ligand for the toll-like receptor 2. J Biol Chem  
14. Babu, M.M., M.L. Priya, A.T. Selvan, M. Madera, J. Gough, L. Aravind, and K. 
Sankaran. 2006. A database of bacterial lipoproteins (DOLOP) with functional 
assignments to predicted lipoproteins. J Bacteriol 188:2761-2773. 
  References 
 118
15. Sibbald, M.J., A.K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H.J. 
Harmsen, G.C. Raangs, I. Stokroos, J.P. Arends, J.Y. Dubois, and J.M. van Dijl. 
2006. Mapping the pathways to staphylococcal pathogenesis by comparative 
secretomics. Microbiol Mol Biol Rev 70:755-788. 
16. Williams, W.A., R.G. Zhang, M. Zhou, G. Joachimiak, P. Gornicki, D. Missiakas, 
and A. Joachimiak. 2004. The membrane-associated lipoprotein-9 GmpC from 
Staphylococcus aureus binds the dipeptide GlyMet via side chain interactions. 
Biochemistry 43:16193-16202. 
17. Cockayne, A., P.J. Hill, N.B. Powell, K. Bishop, C. Sims, and P. Williams. 1998. 
Molecular cloning of a 32-kilodalton lipoprotein component of a novel iron-
regulated Staphylococcus epidermidis ABC transporter. Infect Immun 66:3767-
3774. 
18. Dale, S.E., M.T. Sebulsky, and D.E. Heinrichs. 2004. Involvement of SirABC in 
iron-siderophore import in Staphylococcus aureus. J Bacteriol 186:8356-8362. 
19. Mazmanian, S.K., E.P. Skaar, A.H. Gaspar, M. Humayun, P. Gornicki, J. 
Jelenska, A. Joachmiak, D.M. Missiakas, and O. Schneewind. 2003. Passage of 
heme-iron across the envelope of Staphylococcus aureus. Science 299:906-909. 
20. Morrissey, J.A., A. Cockayne, P.J. Hill, and P. Williams. 2000. Molecular cloning 
and analysis of a putative siderophore ABC transporter from Staphylococcus 
aureus. Infect Immun 68:6281-6288. 
21. Sebulsky, M.T., and D.E. Heinrichs. 2001. Identification and characterization of 
fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in 
Staphylococcus aureus. J Bacteriol 183:4994-5000. 
22. Dumoulin, A., U. Grauschopf, M. Bischoff, L. Thony-Meyer, and B. Berger-
Bachi. 2005. Staphylococcus aureus DsbA is a membrane-bound lipoprotein with 
thiol-disulfide oxidoreductase activity. Arch Microbiol 184:117-128. 
23. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: impact on the 
adaptive immune response. Curr Opin Immunol 9:4-9. 
24. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity 
in the acquired immune response. Science 272:50-53. 
25. Palm, N.W., and R. Medzhitov. 2009. Pattern recognition receptors and control of 
adaptive immunity. Immunol Rev 227:221-233. 
26. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: 
mechanisms and pathways. Immunol Rev 173:89-97. 
27. Kanzler, H., F.J. Barrat, E.M. Hessel, and R.L. Coffman. 2007. Therapeutic 
targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat 
Med 13:552-559. 
28. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate 
immunity. Cell 124:783-801. 
29. Medzhitov, R. 2007. Recognition of microorganisms and activation of the 
immune response. Nature 449:819-826. 
30. Jin, M.S., and J.O. Lee. 2008. Structures of the toll-like receptor family and its 
ligand complexes. Immunity 29:182-191. 
31. Jin, M.S., S.E. Kim, J.Y. Heo, M.E. Lee, H.M. Kim, S.G. Paik, H. Lee, and J.O. 
Lee. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding 
of a tri-acylated lipopeptide. Cell 130:1071-1082. 
  References 
 119
32. Fitzgerald, K.A., D.C. Rowe, and D.T. Golenbock. 2004. Endotoxin recognition 
and signal transduction by the TLR4/MD2-complex. Microbes Infect 6:1361-
1367. 
33. Hayashi, F., K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, D.R. Goodlett, J.K. 
Eng, S. Akira, D.M. Underhill, and A. Aderem. 2001. The innate immune 
response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 
410:1099-1103. 
34. Bauer, S., C.J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. 
Wagner, and G.B. Lipford. 2001. Human TLR9 confers responsiveness to 
bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U 
S A 98:9237-9242. 
35. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, 
K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor 
recognizes bacterial DNA. Nature 408:740-745. 
36. Mancuso, G., M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. 
Teti, and C. Beninati. 2009. Bacterial recognition by TLR7 in the lysosomes of 
conventional dendritic cells. Nat Immunol 10:587-594. 
37. Kagan, J.C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. 
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-
beta. Nat Immunol 9:361-368. 
38. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. 
Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a 
TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263. 
39. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P.F. Muhlradt, S. Sato, K. Hoshino, 
and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent 
pathway and results in activation of IFN-regulatory factor 3 and the expression of 
a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887-5894. 
40. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor 
signalling. Nature 430:257-263. 
41. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S.O. Kim, J. Goode, P. Lin, 
N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han, and B. Beutler. 2003. 
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. 
Nature 424:743-748. 
42. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. 
Takeuchi, K. Takeda, and S. Akira. 2003. TRAM is specifically involved in the 
Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat 
Immunol 4:1144-1150. 
43. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. 
Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of 
adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. 
Science 301:640-643. 
44. Fritz, J.H., R.L. Ferrero, D.J. Philpott, and S.E. Girardin. 2006. Nod-like proteins 
in immunity, inflammation and disease. Nat Immunol 7:1250-1257. 
45. Kufer, T.A., and P.J. Sansonetti. 2007. Sensing of bacteria: NOD a lonely job. 
Curr Opin Microbiol 10:62-69. 
  References 
 120
46. Strober, W., P.J. Murray, A. Kitani, and T. Watanabe. 2006. Signalling pathways 
and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 6:9-20. 
47. Chamaillard, M., M. Hashimoto, Y. Horie, J. Masumoto, S. Qiu, L. Saab, Y. 
Ogura, A. Kawasaki, K. Fukase, S. Kusumoto, M.A. Valvano, S.J. Foster, T.W. 
Mak, G. Nunez, and N. Inohara. 2003. An essential role for NOD1 in host 
recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat 
Immunol 4:702-707. 
48. Girardin, S.E., I.G. Boneca, L.A. Carneiro, A. Antignac, M. Jehanno, J. Viala, K. 
Tedin, M.K. Taha, A. Labigne, U. Zahringer, A.J. Coyle, P.S. DiStefano, J. 
Bertin, P.J. Sansonetti, and D.J. Philpott. 2003. Nod1 detects a unique 
muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-
1587. 
49. Girardin, S.E., I.G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, 
D.J. Philpott, and P.J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan 
through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869-8872. 
50. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, 
S. Inamura, S. Kusumoto, M. Hashimoto, S.J. Foster, A.P. Moran, J.L. 
Fernandez-Luna, and G. Nunez. 2003. Host recognition of bacterial muramyl 
dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 
278:5509-5512. 
51. Abbott, D.W., A. Wilkins, J.M. Asara, and L.C. Cantley. 2004. The Crohn's 
disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a 
novel site on NEMO. Curr Biol 14:2217-2227. 
52. Inohara, N., T. Koseki, J. Lin, L. del Peso, P.C. Lucas, F.F. Chen, Y. Ogura, and 
G. Nunez. 2000. An induced proximity model for NF-kappa B activation in the 
Nod1/RICK and RIP signaling pathways. J Biol Chem 275:27823-27831. 
53. Murray, P.J. 2009. Beyond peptidoglycan for Nod2. Nat Immunol 10:1053-1054. 
54. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive 
immune responses. Nat Immunol 5:987-995. 
55. Bettelli, E., T. Korn, M. Oukka, and V.K. Kuchroo. 2008. Induction and effector 
functions of T(H)17 cells. Nature 453:1051-1057. 
56. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. 
Shamel, T. Hartung, U. Zahringer, and B. Beutler. 2005. CD36 is a sensor of 
diacylglycerides. Nature 433:523-527. 
57. Kielian, T., A. Haney, P.M. Mayes, S. Garg, and N. Esen. 2005. Toll-like receptor 
2 modulates the proinflammatory milieu in Staphylococcus aureus-induced brain 
abscess. Infect Immun 73:7428-7435. 
58. Schmaler, M., N.J. Jann, F. Ferracin, L.Z. Landolt, L. Biswas, F. Gotz, and R. 
Landmann. 2009. Lipoproteins in Staphylococcus aureus mediate inflammation 
by TLR2 and iron-dependent growth in vivo. J Immunol 182:7110-7118. 
59. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and 
MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. 
J Immunol 165:5392-5396. 
60. Gonzalez-Zorn, B., J.P. Senna, L. Fiette, S. Shorte, A. Testard, M. Chignard, P. 
Courvalin, and C. Grillot-Courvalin. 2005. Bacterial and host factors implicated 
  References 
 121
in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect 
Immun 73:1847-1851. 
61. Parcina, M., C. Wendt, F. Goetz, R. Zawatzky, U. Zahringer, K. Heeg, and I. 
Bekeredjian-Ding. 2008. Staphylococcus aureus-induced plasmacytoid dendritic 
cell activation is based on an IgG-mediated memory response. J Immunol 
181:3823-3833. 
62. Sun, Y., A.G. Hise, C.M. Kalsow, and E. Pearlman. 2006. Staphylococcus 
aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and 
myeloid differentiation factor 88. Infect Immun 74:5325-5332. 
63. Hultgren, O.H., L. Svensson, and A. Tarkowski. 2002. Critical role of signaling 
through IL-1 receptor for development of arthritis and sepsis during 
Staphylococcus aureus infection. J Immunol 168:5207-5212. 
64. Miller, L.S., R.M. O'Connell, M.A. Gutierrez, E.M. Pietras, A. Shahangian, C.E. 
Gross, A. Thirumala, A.L. Cheung, G. Cheng, and R.L. Modlin. 2006. MyD88 
mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in 
immunity against Staphylococcus aureus. Immunity 24:79-91. 
65. Kielian, T., N.K. Phulwani, N. Esen, M.M. Syed, A.C. Haney, K. McCastlain, and 
J. Johnson. 2007. MyD88-dependent signals are essential for the host immune 
response in experimental brain abscess. J Immunol 178:4528-4537. 
66. Deshmukh, H.S., J.B. Hamburger, S.H. Ahn, D.G. McCafferty, S.R. Yang, and 
V.G. Fowler, Jr. 2009. Critical role of NOD2 in regulating the immune response 
to Staphylococcus aureus. Infect Immun 77:1376-1382. 
67. Hruz, P., A.S. Zinkernagel, G. Jenikova, G.J. Botwin, J.P. Hugot, M. Karin, V. 
Nizet, and L. Eckmann. 2009. NOD2 contributes to cutaneous defense against 
Staphylococcus aureus through {alpha}-toxin-dependent innate immune 
activation. Proc Natl Acad Sci U S A  
68. Maresso, A.W., and O. Schneewind. 2006. Iron acquisition and transport in 
Staphylococcus aureus. Biometals 19:193-203. 
69. Horsburgh, M.J. 2008. The Response of S. aureus to Environmental Stimuli. In 
Staphylococcus Molecular Genetics. J.A. Lindsay, editor Caister Academic Press, 
Norfolk. 185-206. 
70. Horsburgh, M.J., E. Ingham, and S.J. Foster. 2001. In Staphylococcus aureus, fur 
is an interactive regulator with PerR, contributes to virulence, and Is necessary for 
oxidative stress resistance through positive regulation of catalase and iron 
homeostasis. J Bacteriol 183:468-475. 
71. Alen, C., and A.L. Sonenshein. 1999. Bacillus subtilis aconitase is an RNA-
binding protein. Proc Natl Acad Sci U S A 96:10412-10417. 
72. Cheng, A.G., H.K. Kim, M.L. Burts, T. Krausz, O. Schneewind, and D.M. 
Missiakas. 2009. Genetic requirements for Staphylococcus aureus abscess 
formation and persistence in host tissues. FASEB J  
73. Theurl, I., G. Fritsche, S. Ludwiczek, K. Garimorth, R. Bellmann-Weiler, and G. 
Weiss. 2005. The macrophage: a cellular factory at the interphase between iron 
and immunity for the control of infections. Biometals 18:359-367. 
74. Flo, T.H., K.D. Smith, S. Sato, D.J. Rodriguez, M.A. Holmes, R.K. Strong, S. 
Akira, and A. Aderem. 2004. Lipocalin 2 mediates an innate immune response to 
bacterial infection by sequestrating iron. Nature 432:917-921. 
  References 
 122
75. Wrighting, D.M., and N.C. Andrews. 2006. Interleukin-6 induces hepcidin 
expression through STAT3. Blood 108:3204-3209. 
76. Nemeth, E., M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D.M. Ward, T. 
Ganz, and J. Kaplan. 2004. Hepcidin regulates cellular iron efflux by binding to 
ferroportin and inducing its internalization. Science 306:2090-2093. 
77. Lee, P., H. Peng, T. Gelbart, L. Wang, and E. Beutler. 2005. Regulation of 
hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S 
A 102:1906-1910. 
78. Chambers, H.F., and F.R. Deleo. 2009. Waves of resistance: Staphylococcus 
aureus in the antibiotic era. Nat Rev Microbiol 7:629-641. 
79. Zetola, N., J.S. Francis, E.L. Nuermberger, and W.R. Bishai. 2005. Community-
acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet 
Infect Dis 5:275-286. 
80. Otter, J.A., and G.L. French. 2006. Nosocomial transmission of community-
associated methicillin-resistant Staphylococcus aureus: an emerging threat. 
Lancet Infect Dis 6:753-755. 
81. Skaar, E.P., M. Humayun, T. Bae, K.L. DeBord, and O. Schneewind. 2004. Iron-
source preference of Staphylococcus aureus infections. Science 305:1626-1628. 
82. McLoughlin, R.M., J.C. Lee, D.L. Kasper, and A.O. Tzianabos. 2008. IFN-
gamma regulated chemokine production determines the outcome of 
Staphylococcus aureus infection. J Immunol 181:1323-1332. 
83. Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N. 
Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, K. Sudo, S. Nakae, C. Sasakawa, 
and Y. Iwakura. 2009. Differential roles of interleukin-17A and -17F in host 
defense against mucoepithelial bacterial infection and allergic responses. 
Immunity 30:108-119. 
84. Lappin, E., and A.J. Ferguson. 2009. Gram-positive toxic shock syndromes. 
Lancet Infect Dis 9:281-290. 
85. Bianchi, M.E. 2007. DAMPs, PAMPs and alarmins: all we need to know about 
danger. J Leukoc Biol 81:1-5. 
86. Rittirsch, D., M.A. Flierl, and P.A. Ward. 2008. Harmful molecular mechanisms 
in sepsis. Nat Rev Immunol 8:776-787. 
87. Meng, G., M. Rutz, M. Schiemann, J. Metzger, A. Grabiec, R. Schwandner, P.B. 
Luppa, F. Ebel, D.H. Busch, S. Bauer, H. Wagner, and C.J. Kirschning. 2004. 
Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like 
syndromes. J Clin Invest 113:1473-1481. 
88. Fujimoto, Y., M. Hashimoto, M. Furuyashiki, M. Katsumoto, T. Seya, Y. Suda, 
and K. Fukase. 2009. Lipopeptides from Staphylococcus aureus as Tlr2 Ligands: 
prediction with mrna expression, chemical synthesis, and immunostimulatory 
activities. Chembiochem 10:2311-2315. 
 
 
  Acknowledgements 
 123
6 Acknowledgements 
I would like to express my gratitude to all those who gave me the possibility to complete 
this PhD thesis.  
After finishing my Master thesis in Regine’s Lab, I decided to continue with the project 
on Staphylococcus aureus and its interaction with the host. The friendly atmosphere in 
the Lab and the close contact with the other Lab-members facilitated my decision to stay 
in Basel. As a student from the University of Applied Sciences, it was difficult to 
convince the faculty from the University Basel to be sufficiently qualified for a PhD 
thesis. Therefore I first thank my supervisor Prof. Regine Landmann, Prof. Christoph 
Dehio from the Biozentrum in Basel, and Prof. Günther Schulz from the Fachhochschule 
Lausitz, Senftenberg for their help to get the immatriculation.  
 
I thank my supervisor Regine Landmann for giving me the opportunity to work in her lab 
and for teaching me in Infection Biology. Your constructive criticism and our stimulating 
discussions always motivated me to do it better and your supporting words helped me 
when experiments were not easily to generate.  
 
I thank Christoph Dehio and Cécile Arrieumerlou for always being interested in my 
work, giving many ideas in discussions, and finally as members of my thesis committee. 
 
Naja, when I think about you two episodes come immediately in my mind, first our 
“reading paper and filling bags with Eppendorf tubes” story and second our “spareribs 
  Acknowledgements 
 124
dinner” in the Blue Smoke in New York. How all the meat found a way in your stomach 
is still mysterious. Now, it is time to thank you for supporting and defending me, adding 
my missing commas, and finally for our unique friendship. I cannot say more than 
thanks!  
 
I would like to give my special thanks to the “Cargo Bar Team” consisting of Naja, 
Hatice, Lucie, Eline, Richard, Oli and sometimes Anne who had the patience to discuss 
my scientific work or new Nature publications. My friends, I thank you for the nice time 
in and around the lab in Basel.  
 
I thank “my” or our technicians Fabrizia and Zarko for teaching me in different 
experiments ranging from “simple animal experiments” (citation Zarko) to “schnell mal 
ins Facs heben” and for your help, support, and interest in my research work.  
 
I thank all the former colleagues of Lab 315 and Lab 314 for the nice atmosphere and the 
interesting discussions.  
 
I thank to Prof. Fritz Götz from the University Tübingen for scientific discussions about 
staphylococcal species and providing strains and mutants from his large collection.  
 
I would also like to thank my former and present flat mates and especially Simon for the 
great time at home, who helped to accustom myself in Basel.  
 
  Acknowledgements 
 125
Am Ende möchte meinen Eltern und meinen Grosseltern sowie meiner Schwester und 
ihrer Familie danken. In eurem Umfeld habe ich immer die nötige Geborgenheit 
gefunden, die mir Kraft und Selbstvertrauen für neue Ziele geben. Ohne Eure 
Unterstützung, die positiven Worte und der Liebe, die Ihr mir über all die Jahre habt 
zukommen lassen, wäre ein solcher Lebensweg wie ich ihn nun beschreite nicht möglich 




  Curriculum vitae 
 127
7 Curriculum vitae 
Mathias Schmaler 
Hochstrasse 76, 4053 Basel, Switzerland 
E-Mail: m.schmaler@unibas.ch 
Business address:  Department of Biomedicine, 
Infection Biology, 






Name:   Schmaler 
First Name:  Mathias 
Date of Birth:  September 14
th
 1979 
Place of Birth:  Berlin, Germany 
Nationality:  German 
 
Education 
2006 – 2009  University Hospital Basel, Department Biomedicine, Division of 
Infection Biology, Basel Switzerland 
 
2000 – 2006 Lausitz University of Applied Sciences, Senftenberg, Germany 
 
1999 – 2000 Military Services 
 




Topic of the thesis:  Staphylococcus aureus lipoproteins – TLR2-mediated activation of 
innate and adaptive immunity 




  Curriculum vitae 
 128
Master of Science (2006)  
Topic of my thesis: Interaction of lipoproteins from Staphlylococcus aureus and 
Streptococcus pneumoniae with Toll-like receptor 2 
Supervision:  Prof. Dr. Regine Landmann (Department of Biomedicine, Basel, 
Switzerland) and Prof. Dr. Günther H. Schulz (Lausitz University 
of Applied Sciences, Senftenberg, Germany) 
 
Bachelor of Science (2004) 
Topic of my thesis:  Untersuchungen zur Expression und Lokalisation von M. 
tuberculosis AtpD in Mykobakterien (in English: Analysis of 
expression and localization of M. tuberculosis AtpD in 
mycobacteria) 
Supervision:  Dr. Peter Sander (Institute of Medical Microbiology, University of 
Zurich, Zurich, Switzerland) and Prof. Dr. Günther H. Schulz 
(Lausitz University of Applied Sciences, Senftenberg, Germany) 
 
Practical semester (2002 – 2003)  
Topic of my study: Charakterisierung der Antikörperantwort gegen rekombinante 
Nukleokapsidprotein-Derivate verschiedener Hantaviren in 
Labormäusen (in English: Characterization of antibody responses 
against recombinant nucleocapsidprotein-derivates from different 
hantavirus serotypes in mice) 
Supervision:  Dr. Rainer Ulrich (Institute of Virology, University Hospital 
Charité, Berlin, Germany) and Prof. Dr. Uwe-Karsten Hanisch 






  Curriculum vitae 
 129
Professional Experience 
Introductory Course in Laboratory Animal Science (2006) 
Institute of Laboratory Animal Sciences, University of Zurich, Switzerland 
 
Practical internship (2005) 
Labor Diagnostik GmbH Leipzig, Leipzig, Germany  
Development of an ELISA to detect Prion proteins  
 
Practical internship in a brewery (2000) 
Altmühltaler Heilquellen GmbH, Treuchtlingen/ Bayern, Germany 
 
Publications: 
Geldmacher, A., M. Schmaler, D. H. Kruger, and R. Ulrich. 2004. Yeast-expressed 
hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-
reactive immune response in mice. Viral Immunol 17:115-122. 
 
Karauzum, H., T. Ferry, S. de Bentzmann, G. Lina, M. Bes, F. Vandenesch, M. 
Schmaler, B. Berger-Bachi, J. Etienne, and R. Landmann. 2008. Comparison of adhesion 
and virulence of two predominant hospital-acquired MRSA clones and clonal MSSA 
isolates. Infect Immun 76: 5133-8 
 
Schmaler, M., Jann, N. J., Ferracin, F., Landolt, L. Z., Biswas, L., Gotz, F., Landmann, 
R. 2009. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and 
iron-dependent growth in vivo. J. Immunol 182, 7110-8 
 
Jann, N. J., Schmaler, M., Kristian, S. A., Radek, K. A., Gallo, R. L., Nizet, V., Peschel, 
A., Landmann, R. 2009. Neutrophil antimicrobial defense against Staphylococcus aureus 
is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. J 
Leukoc Biol. 86(5):1159-69 
  Curriculum vitae 
 130
Schmaler, M., Jann, N. J., Gotz, F., Landmann, R. 2009. Staphylococcal lipoproteins and 
their role in bacterial survival in mice. Int J Med Microbiol. Epub ahead of print. 
 
Congress Participation: 
2009 Gordon Research Conference, Staphylococcal Diseases 
Waterville valley (NH), United States (poster presentation) 
2008 41
st
 Annual Meeting of the Society of Leukocyte Biology, Leukocytes: 
Tissue Interactions, Homeostasis, and Host Defense 
Denver (CO), United States (poster presentation) 
2008 Toll 2008 Recent Advances in Pattern Recognition 
Cascais, Portugal (poster presentation) 
2006 Meeting of the Society of Leukocyte Biology and International Endotoxin 
and Innate Immunity Society 
San Antonio (TX), United States (poster presentation) 
2006 20
th
 Annual Meeting of the European Macrophage and Dendritic Cell 
Society, Immunoregulatory and Antimicrobial Activities of Myeloid Cells 
Freiburg, Germany (poster presentation) 
2006 12
th
 International Symposium on Staphylococci and Staphylococcal 
infections 
Maastricht, The Netherlands (poster presentation) 
 
